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ABSTRACT
West Virginia University, School of Pharmacy
Doctoral Dissertation
Caroline Dong

Diesel exhaust particles (DEP) are the major constituent of ambient particulate matter in
urban environments and occupational settings. Exposure to DEP in combination with an
allergen has been demonstrated to enhance allergen-related airway inflammation,
immunoglobulin (Ig) E production, and airway responsiveness (AR) in human and in
animal models. However, the mechanisms behind these effects of DEP are not yet fully
understood. In this study, we compared the effects of short-term DEP exposure on
ovalbumin (OVA)-mediated airway responses under two exposure protocols using an
OVA-allergic rat model. Male Brown Norway rats were sensitized to aerosolized OVA
(40.5 ± 6.3 mg/m3) on days 1, 8, and 15, and challenged with OVA on day 29. The rats
were exposed to DEP (20 mg/m3) for 4 h/day for 5 consecutive days either before
sensitization (protocol A) or before OVA challenge on days 24-28 (protocol B). Control
animals received filtered air and aerosolized saline instead of DEP and OVA,
respectively. The results showed that DEP exposure 1) elicited an adjuvant effect on
OVA-specific IgE and IgG production in serum under both protocols; 2) significantly
reduced OVA-induced airway inflammation and lung injury in protocol A, but increased
these markers in protocol B; 3) markedly lowered OVA-induced production of nitric
oxide, reactive oxygen species, and interleukin (IL)-10 and IL-12 by alveolar
macrophages (AM) in protocol A, but increased these parameters in protocol B; 4)

significantly lowered the numbers of T cells and their CD4+ and CD8+ subsets in lungdraining lymph nodes in protocol A, but increased these cell counts in protocol B; 5)
reduced intracellular glutathione in AM and lymphocytes in both protocols; and 6)
enhanced AR of the OVA-sensitized rats to methacholine challenge in protocol B. These
results suggest that the effects of DEP on the immune system, including aggravation or
exacerbation of asthma, may be greatly influenced by allergic immune status and time of
antigen exposure.
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1. Introduction
Asthma is an airway inflammatory disease characterized by a variable degree of
airflow obstruction, bronchial hyperresponsiveness, and airway inflammation. The most
prevalent form of asthma is allergic asthma. Elevation of allergen-specific
immunoglobulin (Ig)E is one of the hallmarks of allergic diseases. IgG, on the other
hand, has been reported to be related to late-phase asthmatic reactions and mast cell
activation (Durham et al., 1984). An increase in activated CD4+ T helper 2 (Th2) cells in
asthmatic airways after allergen challenge has been recognized for many years (Azzawi
et al., 1990; Robinson et al., 1993), reinforcing an immunological basis for this disease.
An allergic immune response to an allergen is characterized by the production of
interleukin (IL)-4, IL-5, and IL-13 by the Th2 subset of allergen-specific CD4+ T
lymphocytes (Ricci et al., 1994; Foster et al., 1997). IL-4 is the cytokine required for IgE
production, while IL-5 plays a unique role in eosinophil development and activation. In
addition, induction of inducible nitric oxide synthase (iNOS) is also closely associated
with allergic asthma (Trifilieff et al., 2000; Iijima et al., 2001). Allergen-induced nitric
oxide (NO) down-regulates Th1 cytokines but up-regulates Th2 cytokine production
(Trifilieff et al., 2000), and there were close relationships among IL-5, NO, and
eosinophils in ovalbumin (OVA)-challenged mice, where the rise in eosinophils was
accompanied by an increase in iNOS expression and protein nitration on epithelial
surface and peribronchial inflammatory cells (Iijima et al., 2001).

There has been a dramatic increase in the incidence of asthma in many developed
countries during the last decades. Although the causes for this increase are not well
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known, a considerable amount of epidemiological evidence suggests that certain
components of air pollution such as ozone, oxides of nitrogen and particulate matter as
well as a variety of allergens may play important roles (Koren, 1995; Graham, 2004).
Fine particles with widely different composition, such as carbon black (CB), titanium
dioxide (TiO2), polystyrene, polytetrafluoroethylene, residual oil fly ash (ROFA), house
dust, and urban ambient particles, have been reported to exhibit adjuvant effects on the
production of IgE in response to concurrently administered allergens (Ormstad et al.,
1998; Lambert et al., 1999; van Zijverden and Granum, 2000; Hamada et al., 2000;
Granum et al., 2001; Dybing et al., 2004). An important advance in this area is the
discovery that diesel exhaust particles (DEP), a major component of environmental
particulate pollutants in most industrialized urban areas, are implicated in the
development of asthma and aggravation of pre-existing asthma (Lovik et al., 1997;
Takano et al., 1997; Diaz-Sanchez et al., 1994, 1997). DEP, which consist of fine
particulate and about 30% by weight organic materials adsorbed onto the carbonaceous
core, have been shown to exert adjuvant effects on the response of humans and mice to
inhaled or instilled allergens including increased allergen-specific IgE production,
skewing of the immune response to Th2 cytokine production, increased eosinophils in the
bronchoalveolar lavage (BAL) fluid, and increased airway hyperreactivity (Diaz-Sanchez
et al., 1997, 1999; Miyabara et al., 1998; Ohta et al., 1999).

The underlying mechanisms by which DEP exert the adjuvant effects are not yet fully
understood. Most of the studies have been focused on the role of reactive oxygen species
(ROS) produced on exposure to DEP and the subsequent generation of oxidative stress
within the exposed cells. At high concentrations, ROS is responsible for protein
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oxidation, lipid peroxidation, and DNA damage leading cellular damage in target cells
such as macrophages and epithelial cells (Nel et al., 1998; Martin et al., 1997, Becker et
al., 1996). At low oxidative stress levels, as defined by no or minimal changes in the
cellular reduced glutathione (GSH)/glutathione disulfide (GSSG) ratios, the cells mount
antioxidant and cytoprotective responses, e.g., heme-oxygenase 1 (HO-1) and superoxide
dismutase expression (Li et al., 2001). Glutathione is a tripeptide that is found in all
mammalian tissues and is highly concentrated in the liver. Glutathione exists in the
reduced GSH and oxidized GSSG forms (DeLeve and Kaplowitz, 1990). GSH is the
predominant form, existing in millimolar concentrations in most cells whereas the GSSG
content is less than 1% of GSH (Akerboom et al., 1982). GSH has several vital functions
including detoxifying eletrophiles, scavenging free radicals, maintaining the essential
thiol status of proteins by preventing oxidation of -SH groups, providing a pool for
cysteine, and modulating critical cellular processes such as DNA synthesis and immune
function (Diaz-Sanchez et al., 1997)

Studies have shown that DEP may augment both IL-4 and IL-5- dependent allergic
responses (Diaz-Sanchez et al., 1997; Al-Humadi et al., 2002b; Takano et al., 1997), but
the mechanism remains unclear. Evidence indicated that alveolar macrophages (AM),
which are central to the inflammatory process, may play a role in the modulation of T
cell-mediated immunity in an intracellular GSH level-dependent manner. The AM with
high GSH content have shown to transform the naïve Th0 cells to Th1 cells, whereas AM
with low GSH content may transform the naïve Th0 cells to Th2 cells when cultured with
OVA-specific TCR-transgenic mouse spleen cells ( Murata et al., 2002). The
macrophage-mediated Th1/Th2 balance is of significance, since OVA exposure resulted
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in a dose-dependent depletion of GSH in AM that is related to increased antigen-specific
IgE and IgG production in rats (Al-Humadi et al., 2002a). Studies have shown that
pulmonary type II cells may also play a role in modulating T cell activity and promoting
eosinophile-dependent airway inflammation through the secretion of IL-8 and
granulocyte-macrophage colony-stimulating factor (GM-CSF). Evidence showed that the
release of IL-8 and GM-CSF by human bronchial epithelial cells was induced by
recombinant IgE-dependent histamine-releasing factor (HRF-p23), an eosinophile
chemoattractant that is inducible by hydrogen peroxide and is found in increasing levels
in BAL fluid of asthmatic patients (Yoneda et al., 2004).

The adjuvant effect of DEP on allergen-induced airway inflammation has been
demonstrated primarily in various mice models (Ichinose et al., 1997, 2002; Miyabara et
al., 1998; Takano et al., 1997, 1998). Several studies have pointed out that strain
differences in the modulation of allergic airway inflammation and antigen-specific IgE
and/or IgG response by DEP existed, and apparently contradictory effects of DEP were
observed among different mouse models (Ichinose et al., 1997; 2002). Steerenberg and
colleagues (1999, 2003) also reported the use of Brown Norway (BN) rats in elucidating
the adjuvant effect of DEP on timothy grass pollen allergy after intranasal or intratracheal
instillation of DEP in combination with the pollen allergen. In addition, an allergic
asthma model of BN rats has been also established in our laboratory by sensitizing the
animals with aerosolized OVA once a week over a month-long period that produced
significant levels of OVA-specific IgE and IgG (Al-Humadi et al., 2002c). Exposure of
rats to DEP (5 mg/kg) through intratracheal instillation prior to the OVA-sensitization
enhanced production of antigen-specific antibodies at the end of allergen sensitization,
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and this enhancement correlated with an increase in IL-4 mRNA expression in lung
tissue. Up to the present, the adjuvant effect of DEP was demonstrated mainly from
studies where DEP were administered in combination with an allergen during the
sensitization process, or already-sensitized human/animal models were employed. In
practical settings, however, subjects may be sensitized or non-sensitized to allergen(s),
and may encounter DEP and allergen exposure at the same or different times. Different
exposure protocols for the timing of DEP and allergen exposures therefore should be
pursued in order to gain insight into the complex effects of DEP on the pulmonary
immune system. One of the important concerns raised is whether DEP, when given
separately from an allergen, can have the adjuvant effect, i.e., augmentation of specific
IgE or IgG response to an allergen encountered before or after DEP exposure.

Another important question regarding the involvement of DEP in allergic asthma is
whether DEP may contribute to the chronic airway inflammation that has been
recognized as an essential feature of the disease. A number of studies pointed out that
fine and ultrafine particles, such as DEP, CB, ROFA, and metal particles, have the
potential to trigger inflammatory mechanisms by modulating intracellular calcium
concentrations, activation of transcription factors, and production of inflammatory
cytokines through an oxidant-mediated mechanism (Sagai et al., 1996; Dick et al., 2003;
Brown et al., 2004). These particles have also been shown to aggravate the antigeninduced inflammation when given together with an antigen (Lovik et al., 1997; Takano et
al., 1997; Ichinose et al., 2002). DEP are carbon-based particles containing approximately
30% by weight various organic compounds, including PAHs, nitroaromatic compounds,
quinones, aldehydes, and heterocyclic compounds, adsorbed onto the carbonaceous core
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(Schuetzle, 1983; Draper, 1986). Due to the complexity of their chemical properties, DEP
may be different from the other particles in their modulating effect on inflammatory
response and pulmonary immunity. Indeed, a study by Melgert et al. (2004) showed that
short term exposure of mice to cigarette smoking, a complex mixture containing fine
carbonaceous particles and various organic compounds, inhibited OVA-induced airway
inflammatory responses. Studies from our laboratory have previously shown that DEP or
their organic extracts, but not the carbonaceous core, CB or silica, suppress the
production of lipopolysaccharide (LPS)-stimulated pro-inflammatory cytokines tumor
necrosis factor (TNF)-α and IL-12, but increase the production of anti-inflammatory IL10 by rat AM (Yang et al., 1999; Yin et al., 2004a, b). Previous results have shown that
DEP aggravate OVA-induced airway inflammation when given together with the antigen
(Takano et al., 1997, 1998; Miyabara et al., 1998; Ichinose et al., 2002). However, shortterm exposure to DEP prior to sensitization may exert an anti-inflammatory effect which
potentially attenuates the allergen-induced airway inflammation.

The objectives of this study were to develop rat models in which animals were
exposed to DEP before or after sensitization, and use these models to examine the effects
of short-term DEP exposure on allergen-induced IgE and IgG production and allergic
airway inflammation. We hypothesize that DEP exposure prior to OVA sensitization
(protocol A) augments the sensitization process but inhibits airway inflammation though
AM orchestrated anti-inflammatory effect, while DEP exposure after the sensitization
(protocol B) augments allergic responses and airway hyperreactivity through, in part, by
activation of epithelial type II cells. To investigate the underlying mechanism of these
effects, we measured alterations in intracellular GSH levels, production of NO and
6

cytokines by AM and lymphocytes from lung-draining lymph nodes (LDLN), expression
of iNOS in lung tissue, and alterations of CD4+ and CD8+ T cell subsets in LDLN.
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2. Literature Review
2.1 Introduction
The health effects of diesel exhaust (DE) have received increasing attention over the
past decades. Since early 1980’s, considerable epidemiological evidence has accumulated
to indicate that DE may exert significant adverse effects on humans. Exposure to DE may
induce a variety of conditions including increased morbidity and mortality of lung cancer,
allergic asthma, chronic obstructive pulmonary disease (COPD), and cardiovascular
disorders. Experimental studies, both in vivo and in vitro, have been performed in order
to understand the relevance of associations found in the epidemiological studies and the
molecular and cellular mechanisms of actions. For the risk assessment of DE exposure,
researches on the potential biomarkers of exposure, effects, and susceptibility have been
also conducted. The aim of this review is to provide a summary of the current state of
knowledge regarding environmental and occupational exposures to DE, epidemiological
and experimental evidence for the adverse effects of DE exposure on human health,
biomarkers for risk assessment, and the mechanisms by which DE exposure exerts its
adverse health effects on humans.

2.2 DE Exposures

Air pollution caused by motor vehicle exhaust has been a significant environmental
and occupational health concern and the focus of many studies for the last decades.
Among the motor vehicle generated air pollutants, DE, emitted by heavy-duty diesel
engines, is a major health concern. The heavy-duty diesel engines, which are being
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increasingly utilized for their high fuel efficiency and low levels of carbon dioxide
emission, produce 30-100 times more particulate matter (PM) than the gasoline engines,
making diesel exhaust particles (DEP) one of the major components of airborne PM in
most urban and industrialized areas (Ma and Ma, 2002). DEP are carbon-based particles
containing over several hundred different organic and inorganic components, including
polycyclic aromatic hydrocarbons (PAHs), quinones, aldehydes, nitroaromatic and
heterocyclic compounds, and traces of heavy metals such as iron, copper, chromium, and
nickel, adsorbed onto the carbonaceous core (Schuetzle, 1983; Vouk et al., 1983). With a
mass median diameter of approximately 0.2 µm and over 80% of particles being in the
size range around 0.1 µm, DEP can remain airborne for long periods of time and deposit
in great numbers deeply in the lungs (Sydbom et al., 2001). Although data are not
available on long-term retention of DEP in human lungs, it has been estimated from
animal studies that about one-fourth of the particles mass inhaled by people is deposited
in the deeper pulmonary regions, and some of which is retained with a half-life of several
hundred days or more (McClellan, 1987). In addition to DEP, DE contains a complex
mixture of toxic gases such as nitrogen oxides (NOx), sulphur dioxide (SO2), carbon
monoxide (CO), hydrocarbons, and formaldehyde (Scheepers and Bos, 1992).

Ambient concentrations of DEP vary markedly from different areas. While the
ambient concentrations of DEP nationwide are relatively low, levels of DEP in certain
urban areas can be considerable higher. In the Los Angeles Basin, for example, one
estimate has placed the rate of DEP intake by humans at 0.3 mg every 1-3 days (DiazSanchez, 1997). According to a report prepared by EPA (U.S. EPA, 2002), the seasonal
and annual average DEP concentrations in nonurban areas before 1990 ranged from 2-5
9

µg/m3. DEP concentrations for urban areas in the same timeframe ranged from 4.4-13
µg/m3, with concentrations on individual days ranging up to 22 µg/m3. Ambient
measurements taken in 1990 or later suggest that seasonal or annual average DEP levels
ranged from 0.2-2.6 µg/m3, with maximum reported values ranging up to 3.4 µg/m3 in
suburban/nonurban locations. DEP concentrations in urban areas measured in the same
timeframe ranged from 1.7-3.6 µg/m3, with maximum concentrations up to 7.3 µg/m3.
The highest DEP concentrations reported were those in the vicinity of a bus stop in
midtown Manhattan, which ranged from 13.2-46.7 µg/m3. Information regarding DEP in
occupational settings suggests a considerably higher exposure, raising an important
health concern for exposure of truckers, railroad and construction workers, engine
mechanics, and especially, underground miners. A report from the Department of Labor
showed that the worst-case mean exposures to DEP in underground metal and nonmetal
mines are about 2000 µg/m3, with maximum measurements as high as 3650 µg/m3 (U.S.
Department of Labor, Mine Safety, and Health Administration, 1998). As reported by
EPA (U.S. EPA, 2002), DEP exposure ranges up to approximately 1,280 µg/m3 for
miners, with lower exposure measured for railroad workers (39-191 µg/m3), firefighters
(4-748 µg/m3), public transit personnel who work with diesel equipment (7-98 µg/m3),
mechanics and dockworkers (5-65 µg/m3), truck drivers (2-7 µg/m3), and bus drivers (1-3
µg/m3). The estimated 70-year lifetime exposures equivalent to those for the occupational
groups discussed above range from 0.4-2 µg/m3) on the low end to 2-269 µg/m3) on the
high end (U.S. EPA, 2002).

2.3 Health Effects of DEP: Epidemiological Studies
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General Pulmonary Symptoms and Lung Function

Epidemiologic evidences showed that both chronic exposure to lower concentrations
of DE and acute exposure to high level of DE are associated with some respiratory
symptoms. Brunekreef et al. (1997) studied children in six areas located near major
motorways and assessed their exposure to traffic-related air pollution using separate
traffic counts for automobiles and trucks in the Netherlands. The results showed that
children living on busy streets were more likely to develop chronic respiratory symptoms
than those living on streets with less traffic, with the association becoming stronger in
children living closest (< 300 m) to the motorways. Lung function was associated with
truck traffic density but had a lesser association with automobile traffic density. The lung
function was also associated with the concentration of black smoke measured inside the
schools. These results indicated that exposure to traffic-related DE may lead to reduced
lung function in children living near major motorways.

Occupational DE exposure occurs within working environments and usually at
relatively high concentrations, making it possible for researchers to examine DEassociated health effects. The results are mixed. In a study of coal miners exposed or
unexposed to DE, Reger et al. (1982) showed that persistent cough and phlegm were
significantly higher in DE exposed workers, but the opposite was found for dyspnea.
Compared with nondiesel-exposed workers, DE-exposed workers had significant
decrease in forced vital capacity (FVC), forced expiratory volume in 1 sec (FEV1), and
forced expiratory flow (FEF) rates. Yet, in a study of diesel bus garage workers, Gamble
et al. (1987a) showed that diesel bus garage workers had elevated prevalence of cough,
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phlegm, and wheezing compared to "blue-collar" workers, but there was no association
with tenure. When NO2 and respirable particles were determined with personal samplers
and used as a surrogate measure of DE, both NO2 and respirable particle exposures were
associated with increased postwork shift symptoms of cough, difficult or labored
breathing, chest tightness, and wheeze but not with lung function (Gamble et al., 1987b).
The same research group also studied the effects of DE exposure on salt miners (Gamble
and Jones, 1983a, 1983b). There was a nonsignificant increased trend for cough and
dyspnea and a significant trend for phlegm by years of tenure in DE-exposed jobs, but no
association with lung function (Gamble and Jones, 1983a; Gamble et al., 1983b). Other
studies examining the health effects of DE exposure in underground potash or coal mines
also found that measured lung function and symptoms were not associated with the
cumulative NO2 exposure (Attfield et al., 1982; Robertson et al., 1984). The health
effects of DE exposure have also been evaluated in farmers exposed to DE while
working. The results showed that driving diesel tractors was associated with a duration
dependent increase in odds ratio (OR) of wheeze (OR = 1.31, 95% confidential interval
[CI] 1.13-1.52) comparing to driving gasoline tractors (OR = 1.11, 95% CI 1.02-1.21).

Chronic Obstructive Phulmonary Disease (COPD)

COPD is a progressive syndrome of expiratory airflow limitation caused by chronic
inflammation of the airways and lung parenchyma. Increasing in incidence, COPD is the
fourth leading cause of death in the United States and also a leading cause of morbidity
and mortality worldwide. Occupational exposure to respiratory silica and other inorganic
dusts, has been associated with COPD (Hnizdo and Vallyathan, 2003; Bergdahl et al.,
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2004). Studies have also shown that exposure to vehicle motor exhaust may also
contribute to the risk for morbidity and mortality of this disease. In a consecutive cross
sectional study conducted during 1985-1994 in the Rhine-Ruhr Basin of Germany,
Schikowski et al. (2005) reported that chronic exposure to PM10, NO2 and living near a
major road might increase the risk of developing COPD and can have a detrimental effect
on lung function in women. Women living less than 100 m from a busy road had an
increased risk for COPD (1.79 times, 95% CI 1.06-3.02) and a significantly decreased
lung function compared with those living farther away. In another cross sectional
investigation, Ulvestad et al. (2000) studied the risk of COPD in 212 tunnel workers and
a reference group of 205 other heavy construction workers in Norway. Compared with
the reference subjects the tunnel workers had a significant decrease in FVC % predicted
and FEV1 % predicted when related to years of exposure. Adjusted FEV1 decreased by
17 ml for each year of tunnel work exposure compared with 0.5 ml in outdoor heavy
construction workers. The tunnel workers also reported significantly higher occurrence of
respiratory symptoms. The prevalence of COPD was 14% in the tunnel workers
compared with 8% in the reference subjects. Other studies showed that occupational
exposure to motor vehicle pollution or among construction workers only had a marginally
increased prevalence or mortality of COPD (Fleming and Charlton, 2001; Bergdahl et al.,
2004). Recently Hart et al. (2006) recently reported a case-control study of railroad
worker deaths between 1981 and 1982 which consisted of 536 cases with COPD and
1,525 controls with causes of death not related to DE or fine particle exposure. After
adjustment for age, race, smoking, U.S. Census region of death, vitamin use, and total
years off work, engineers and conductors with DE exposure from operating trains were
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found to have an increased risk of COPD mortality. The odds of COPD mortality
increased with years of work in these jobs, and those who had worked 16 years or longer
as an engineer or conductor after 1959 had an OR of 1.61 (95% CI, 1.12-2.30). These
results suggest that DE exposure contributed to COPD mortality in these workers.

Asthma

There has been a rapid increase in the prevalence of allergic diseases such as allergic
asthma in the last decades. Asthma is a chronic respiratory disease manifested by
bronchial hyperresponsiveness, reversible bronchial constriction, airway inflammation,
and respiratory symptoms such as wheezing, dyspnea, coughing, and chest tightness
(Busse et al., 2001). The increase in asthma and other allergic diseases has been a global
phenomenon in industrial countries, which can not be attributed to genetic changes, but is
assumed to be related to changes in environmental factors, including airborne PM, NOx,
SO2, and ozone (Liccardi et al., 1998). DE, in addition to DEP, contains a complex
mixture of gases such as CO, NOx, SO2, which may all contribute to the increased
prevalence of asthma. Considering the health effects, recent focus has been on DEP, one
of the major components of airborne PM in most urban and industrialized areas.

An early cross-sectional study has shown that the prevalence of cedar pollen allergy
was higher near busy highways despite equivalent local exposure to cedar pollen in lessbusy areas (Ishizaki et al., 1987). This is among the earliest studies providing evidence on
the relation between motor vehicle exhaust exposure and allergy. Since then, numerous
epidemiological studies have shown associations between traffic density and prevalence
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or morbidity of asthma. Observations have shown that children raised in more polluted
regions of a country are more likely to develop respiratory diseases and allergies
compared with children raised in “cleaner” regions (Heinrich et al., 1999). In Japan,
studies have suggested that children living close to roads with heavy traffic are more
likely to develop allergies (D'Amato et al., 1998). A Germany study showed that more
than 3,700 adolescent students who were living on streets with “constant” truck traffic
were 71% more likely to report symptoms of allergic rhinitis and more than twice were
likely to report wheezing symptom (Duhme et al., 1996). Brauer et al. (2002) examined
the relationship between traffic-related air pollution and the development of
asthmatic/allergic symptoms and respiratory infections in a birth cohort (approximately
4,000) study in The Netherlands. The results showed that the adjusted ORs for wheezing,
physician-diagnosed asthma, ear/nose/throat infections, and flu/serious colds positively
associated with concentrations of air pollutants (NO2, PM2.5, and soot). These data,
however, could not distinguish the specific role of DE exposure in asthma morbidity from
that of the other forms of exhausts. A few studies have been performed with
consideration of the DE effects under urban exposure. A European panel study of 61
children, of whom 77% were taking asthma medication, showed stronger associations for
black smoke than for PM10 and ozone in relation to peak expiratory flow (PEF),
respiratory symptoms, and bronchodilator use (Gielen et al., 1997). The authors
hypothesized that black smoke may be a better surrogate for fine particles emitted by
diesel engines or for the other chemicals that may be the causal components in DE.
Oliver et al. (2001) reported that laborers, tunnel workers, and operating engineers who
were exposed to DE in heavy and highway and tunnel construction were at increased risk
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for asthma, of which tunnel workers also appeared to be at increased risk for chronic
bronchitis. In a cross-sectional study of 76 DE-exposed dockers and 63 reference
subjects, Mastrangelo et al. (2003) found that long-standing exposure of non-atopic
dockers to DE at concentrations similar to those in heavily polluted cities increased
serum IgE levels (OR = 11.4; 95% CI 1.44-526), but not the incidence of rhinitis or
asthma. Moreover, none of the OR was significant among atopic individuals. However,
Wade and Newman (1993) have described in a case report that three railroad workers
who traveled in locomotive units right behind the diesel powered locomotive engine
eventually developed asthma, which persisted 1-3 years. One individual's PEF rates fell
in a work-related pattern when riding immediately behind the lead diesel engine. In two
cases, physiologic abnormalities suggesting reversible restriction were observed. None
had a previous history of asthma or other respiratory disease and none were smokers.
This is the only report clearly implicating DE exposure as a cause of reactive airways
disease, which was named “diesel asthma” by the authors.

Lung Cancer

DE contains high concentrations of respirable carbonaceous particles with absorbed
organic and inorganic chemicals. Recognition that some of these compounds are
mutagenic and carcinogenic agents has raised concern for the cancer-causing potential of
DE exposure. DEP is known to cause lung cancer at least in rats (Mauderly et al., 1987)
through chronic inhalation exposure. The combination of chemical data, genotoxicity,
and experimental carcinogenicity has led the conclusion by National Institute for
Occupational Safety and Health (NIOSH) that a potential carcinogenic hazard exist
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amongst those exposed to DE (NOISH, 1988). The International Agency for Research on
Cancer (IARC) to classify DE as a probable human carcinogen (IARC, 1989). Since then,
extensive epidemiologic studies, mainly on lung cancers, among exposed workers have
been conducted, and provided evidence that occupational exposure to diesel motor
emissions may be associated with an increased risk in developing lung cancer.

There have been no fewer than a dozen of epidemilolgical reports demonstrated the
risk of DEP-induced cancer in various workers (Garshick et al. 1987, 1988, 2004, 2006;
Laden et al., 2006; Bunn et al., 2002, U.S. EPA, 2002; Saverin et al., 1999; California
EPA, 1997; Steenland et al., 1998; Stayner et al., 1998). Boffetta and colleagues (Boffetta
et al., 1988) showed that in U.S., railroad workers, heavy equipment operators, miners,
and truck drivers had a higher mortality both for all causes and for lung cancer when
compared with subjects with other occupations and no exposure to DE. Truck drivers
exposed to DE were not at excess risk of lung cancer when compared with truck drivers
unexposed to DE, but showed a trend of increasing risk with duration of exposure.
Similar results have been also obtained in an investigation on the risk of lung cancer
among male and female workers exposed to DE in a large record-linkage study. In
Sweden studies by Boffetta et al., (2001) showed that men exposed to DE in the 1960
census experienced an increased risk of lung cancer with the RR of 0.95 (95% CI 0.91.0), 1.1 (95% CI 1.1-1.2), and 1.3 (95% CI 1.3-1.4) for low, medium, and high intensity
of exposure, respectively. The risk was higher for squamous cell carcinoma of the lung
than for other histological types. In a 1979-1985 population-based case-control study
conducted in Montreal, Canada, Parent et al. (2006) demonstrated that an increased risk
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in lung cancer was associated with exposure to DE, after adjustments for potential
confounders, but not with exposure to gasoline exhaust.

In total, these studies have established a relationship between DE exposure and lung
cancer with various workers, including miners, railroad workers and professional drivers
(e.g., trucks, buses, and taxies and found correlation between increased risk in cancer and
duration of DE exposure.

Cardiovascular Effects

Air pollution not only exerts respiratory effects, but also increases cardiovascular
morbidity and mortality (Peters et al., 1999). Epidemiological studies have associated
increased mortality in cardiovascular diseases with heavy air pollution (Dockery and
Pope, 1994, Schwartz, 1994). Some recent studies have shown that exposure to
particulate air pollution may increase the susceptibility to ischemic heart diseases (IHD)
and the occurrence of myocardial infarction (Pekkanen et al., 2002; Peters et al., 2001;
Zanobetti and Schwartz, 2005).

Several studies have linked the exposure to vehicle exhaust with various
cardiovascular responses. In a cohort study by Hoek et al. (2002), the risk of death from
cardiopulmonary causes in persons living close to a major road or highway was two times
higher than those living farther from a major road or highway, after adjustment for risk
factors such as age, sex, and smoking status (Hoek et al., 2002). Le Tertre et al. (2002)
examined the association between airborne particles and hospital admissions for cardiac
causes in eight European cities. The pooled percentage increases associated with a 10
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µg/m3 increase in PM10 and black smoke were 0.5% (95% CI 0.2-0.8) and 1.1% (95%
CI: 0.4 to 1.8) for cardiac admissions of all ages, 0.7% (95% CI 0.4-1.0) and 1.3% (95%
CI 0.4-2.2) for cardiac admissions over 65 years, and, 0.8% (95% CI 0.3-1.2) and 1.1%
(95% CI 0.7-1.5) for IHD over 65 years. Analysis of the effects of particulate air
pollution on cardiac admissions suggested the primary effect was likely to be mainly
attributable to DE. In a retrospective cohort mortality study, Finkelstein et al. (2004)
compared the risk of IHD mortality among heavy equipment operators to that of
members of other construction unions. Two hundred fifty nine of 1,009 deaths among the
heavy equipment operators were attributed to IHD, with a proportional mortality ratio of
1.09 (95% CI 0.96-1.2). The mortality for IHD mortality, comparing the heavy
equipment operators to all other workers combined was 1.47 (95% CI 1.17-1.84) for ages
25-64, 1.20 (95% CI 0.96-1.50) for ages 65 or more, and 1.32 (95% CI 1.13-1.55) for all
ages combined. In a case control study by Gustavsson et al. (2001), the risk of
myocardial infarction from occupational exposure to motor exhaust, other combustion
products, organic solvents, lead, and dynamite was investigated. The RR of myocardial
infarction was 2.11 (95% CI 1.23-3.60) among those who were highly exposed and 1.42
(95% CI 1.05-1.92) among those who were intermediately exposed to combustion
products from organic material. The other exposures were not consistently associated
with myocardial infarction, while a possible association between exposure to dynamite
and organic solvents with an increased risk was observed. A later case control study by
the same group indicated that occupational exposure of professional drivers might
contribute to their risk for myocardial infarction (Bigert et al., 2003). The crude ORs for
myocardial infarction were 2.14 (95% CI 1.34-3.41), 1.88 (95% CI 1.19-2.98), and 1.66
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(95% CI 1.22-2.26), among bus, taxi, and truck drivers. Adjustment for potential
confounders gave lower but still increased ORs of 1.49 (95% CI 0.90-2.45), 1.34 (95%
CI 0.82-2.19) and 1.10 (95% CI 0.79-1.53), respectively. The authors concluded that the
work environment of these professional drivers might contribute to their increased risk
for myocardial infarction. These studies indicated that environmental and occupational
exposure to DE had adverse effects upon the cardiovascular system that increase risk of
morbidity and mortality of cardiovascular diseases such as IHD and/or myocardial
infarction.

2.4 Experimental Studies

Human Studies on DE Exposure and Asthma
Experimental studies using human subjects have shown that DEP induce airway
inflammation, thus playing a role in the increase prevalence of allergic diseases. In a
study by Salvi et al. (1999), fifteen healthy volunteers were exposed to a high
concentration of DEP (300 µg/m3) in a chamber for 1 h. At 6 h after exposure there was
a significant increase in the number of neutrophils, mast cells, CD4+ and CD8+
lymphocytes in the airway mucosa, suggesting DEP may enhance inflammatory cell
infiltration from blood vessel to the airway. Furthermore, an elevated concentration of
methyl-histamine was detected in the bronchoalveolar lavage (BAL) fluid, indicating an
increased degranulation of mast cells. However, lung function was unaffected by DEP
exposure in contrast to the increased inflammatory cell infiltration detected in the
airways, suggesting that lung function measurements alone cannot be used to exclude
adverse effect of DEP. Other similar studies using healthy nonsmoker volunteers exposed
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to DEP (200-300 µg/m3) for 1-2 h also showed an inflammatory responses in the airways
(Nordenhall, 2000; Nightingale et al., 2000).
Individuals with asthma have inflamed airways and are clinically more sensitive to air
pollutants than control subjects. PM pollution adversely affects the airways, with
asthmatic subjects thought to be especially sensitive. Several studies have been conducted
to examine whether motor vehicle-derived air pollution or DE would promote asthmatic
reactions in mild allergic asthma. In a study by Svartengren et al. (2000), volunteers with
mild allergic asthma were exposed to air for 30 min in a city road tunnel or in a suburban
area with much lower pollution levels. Although subjective symptoms during tunnel
exposure were not pronounced, subjects exposed to tunnel NO2 levels at or higher than
300 µg/m3 had a significantly greater early reaction following a low dose of allergen
inhalation as well as lower lung function (FEV1) and more asthma symptoms during the
late phase compared to controls. Also, subjects with PM2.5 exposure at or higher than
100 µg/m3 had a slightly increased early reaction compared to controls. These data
suggested that exposure to motor vehicle-derived air pollution may significantly enhance
asthmatic reactions to subsequently inhaled allergens. In other studies on the effects of
DE exposure on asthmatic reactions, Holgate and colleagues (Holgate et al., 2003;
Stenfors et al., 2004) reported an increase in airway resistance of similar magnitude in
both healthy and mild asthmatic subjects 2 h after exposed to ambient levels of DE.
Healthy subjects, but not subjects with mild asthma, developed airway inflammation 6 h
after DE exposure, with airways neutrophilia and lymphocytosis together with an
increase in interleukin (IL)-8 protein in BAL fluid, bronchial mucosa and upregulation of
the endothelial adhesion molecules, suggesting low level DE exposure did not induce a
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neutrophilic response or exacerbated their pre-existing eosinophilic airway inflammation
(Holgate et al., 2003). When the asthmatic subjects were exposed to high concentration of
DE, however, worsen lung function and asthmatic responses were noted by the same
group (Nordenhall et al., 2001). In this study, fourteen atopic asthmatics with stable
disease and on continuous treatment with inhaled corticosteroids were exposed to DE
(300 µg/m3 PM10) for 1 h. Exposure to DE was associated with a significant increase in
airway resistance immediately after the exposure and the degree of hyperresponsiveness
to methacholine at 24 h after exposure, compared to air control subjects. These studies
indicated that short-term exposure to high levels of DE is associated with adverse effects
in asthmatic airways, even in the presence of inhaled corticosteroid therapy.

DEP have been shown to potentiate IgE production in human respiratory mucosal
membranes or even lead to primary sensitization of humans by driving a de novo mucosal
IgE response. A human nasal challenge study was performed in which human subjects
were exposed to various doses of DEP to investigate the effect of DEP on the production
of localized immunoglobulins. Four days after challenge with 0.3 mg DEP, increased
production of IgE but not other immunoglobulins was detected (Diaz-Sanchez et al.,
1994). Studies have also shown that DEP may have an adjuvant effect to allergens on
human subjects. Ragweed-sensitive individuals were exposed to 0.3 mg DEP and
ragweed. Ragweed challenge alone enhanced the production of IgE, IgG4, and also
allergen-specific IgE in the BAL fluid. However, in DEP and ragweed combined exposed
group, there was a 16-fold increase in ragweed-specific IgE. Although DEP alone
enhanced total IgE, it was the combination of DEP and ragweed that led to an increased
production of ragweed-specific IgE and an increased expression of T helper type 2 (Th2)
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cytokines (Diaz-Sanchez et al., 1994). Data from these human studies suggested that DEP
may play a role in the increase prevalence of allergic diseases by enhancing Th2
responses and IgE production. In another study, Diaz-Sanchez et al. (1999) examined the
ability of DEP exposure to lead to primary sensitization of humans. Atopic subjects were
immunized with a neoantigen keyhole limpet hemocyanin (KLH) and DEP were
administered 24 h before each KLH exposure. Exposure to KLH alone led to the
generation of an anti-KLH IgG and IgA humoral response, which was detected in nasal
fluid samples. In contrast, when challenged with KLH preceded by DEP, 9 of the 15
subjects produced anti-KLH-specific IgE. KLH-specific IgG and IgA at levels similar to
that seen with KLH alone could also be detected. Subjects who received DEP and KLH
had significantly increased IL-4, but not interferon (IFN)-γ, in nasal lavage fluid, whereas
these cytokines were unchanged in subjects receiving KLH alone. These studies
demonstrated that DEP can not only potentiate IgE production in human respiratory
mucosal membranes, but also act as mucosal adjuvant to a de novo IgE response and may
increase allergic sensitization.

Human Studies on DE Exposure and Cardiovascular Diseases

Human studies suggested that PM has the potential to affect important cardiovascular
parameters. It has been shown that acute exposure to air pollution resulted in increased
plasma viscosity (Peters et al., 1997) and increased infiltration of inflammatory cells in
the blood (Salvi et al., 1999). Ultra-fine particles were shown to provoke alveolar
inflammation with release of mediators capable of causing exacerbations of lung disease
and of increasing blood coagulability in susceptible individuals, thus explaining the

23

observed increases in cardiovascular deaths associated with urban pollution episodes
(Seaton et al., 1995). Another report showed that exposure to PM led to changes in
haemoglobin concentration, haematocrit and red blood cell counts and decreased platelet
number and fibrinogen levels (Seaton et al., 1999). Peters et al. (2004) conducted a casecrossover study to assess whether exposure to traffic can trigger myocardial infarction.
An association was found between exposure to traffic and the onset of a myocardial
infarction within one hour afterward (OR = 2.92; 95% CI 2.22-3.83). The time the
subjects spent in cars, on public transportation, motorcycles, or bicycles was consistently
linked with an increase in the risk of myocardial infarction. The subject's use of a car was
considered to be the most common source of exposure to traffic, while the time spent on
public transportation was associated with the onset of a myocardial infarction one hour
later. These results showed that transient exposure to traffic might increase the risk of
myocardial infarction in susceptible persons. A recent human study further showed that
compared to air controls, short-term inhalation exposure of healthy men to DE, at levels
encountered in an urban environment, impairs the regulation of vascular tone and
endogenous fibrinolysis, two important and complementary aspects of vascular function
in humans (Mills et al., 2005). These important findings provide a potential mechanism
that links DE to the pathogenesis of atherothrombosis and acute myocardial infarction.

Modulation of the Pulmonary Immune Responses

In recent years, ambient air pollution has been associated with hospitalizations and
deaths due to exacerbations of cardiovascular and respiratory diseases (Samet, 2000).
Increasing evidence shows that DEP may exert a strong modulating effect on the

24

pulmonary immune system. Particularly, DEP and other particulate air pollution have
been linked to asthma (Norris et al., 1999; Lipsett et al., 1997; D'Amato, 1999). DEP can
act as nonspecific airway irritants at relatively high levels. At lower levels, DEP promote
release of specific cytokines, chemokines, immunoglobulins, and reactive oxygen species
(ROS), which are central chemical messengers in the inflammatory processes of asthma.
Release of these mediators of the allergic and inflammatory response initiates a cascade
that can culminate in airway inflammation, mucus secretion, serum leakage into the
airways, and bronchial smooth muscle contraction (Pandya et al., 2002). In addition,
modulation of the pulmonary immune responses by DEP is also directly associated with
their adverse effect on pulmonary infections (Yang et al, 2001; Yin et al., 2002, 2003,
2004a, 2004b, 2005, 2006).

The cytotoxicity and immune-modulating effects of DEP have been examined in a
number of studies using human bronchial and nasal epithelial cells. DEP exposure led to
cell membrane damage in a dose- and time-dependent manner. Transmission electron
microscopy study showed that DEP underwent endocytosis and translocated into
epithelial cells (Boland et al., 1999). When the nasal or bronchial epithelial cells were
exposed to DEP, their synthesis and release of proinflammatory cytokines such as IL-1,
IL-6, IL-8, adhesion molecules, and granulolcyte-macrophage colony-stimulating factor
(GM-CSF), were significantly increased (Devalia et al., 1997; Boland et al., 1999). Study
found that carbon black (CB) particles, which resembled the carbonaceous core of DEP,
had no effect on cytokine release, suggesting the cytokine effect appeared to be attributed
to the adsorbed organic compounds (Boland et al., 1999). Furthermore, DEP were shown
to induce the degranulation of eosinophils and enhance their adhesiveness to epithelial
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cells without changing the eosinophils survival rate, suggesting that DEP are likely to
play an important role in promoting nasal hypersensitivity induced by increased
eosinophil infiltration and degranulation (Terada et al., 1997). In a recent study,
Mamessier et al. (2006) assessed the effect of DEP on the activation of T-cells, the main
cells orchestrating asthma inflammation. The study showed that DEP could activate Tcells in asthmatics only, with a higher effect occurring during exacerbations.

IL-8, a member of CXC chemokine family mainly produced by macrophages, is one
of the key mediators in attracting neutrophils to the airways (Lezcano-Meza et al., 1999).
Since neutrophils are the most important inflammatory leukocytes in airway secretions of
patients with acute severe asthma (Ordonez et al., 2000), the effect of DEP on the
secretion of IL-8 is significant. In a study by Bayram et al. (1998a), DEP exposure
attenuated the ciliary beat frequency of human bronchial epithelial cells and increased
their release of IL-8, GM-CSF, and soluble intercellular adhesion molecule (ICAM)-1.
Increased production of IL-8 was also observed in bronchial washings and bronchial
tissues of healthy human volunteers after exposure to DEP (Salvi et al., 2000). In another
study, the effects of DEP on the production of IL-8 by cultured human bronchial cells
were compared between healthy volunteers and atopic patients with mild asthma. There
was a significant increase in the levels of IL-8 in the bronchial cells from asthmatic
patients when they were treated by 10 µg/ml DEP. In the cells from nonasthmatics, only
higher concentrations of DEP (50 and 100 µg/ml) caused an increase in the release of IL8. The results indicated that the bronchial cells from asthmatic patients were more
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sensitive to DEP than those from nonasthmatics and that the DEP-mediated IL-8
production may play a role in asthmatic responses (Bayram et al., 1998b).

DEP may also promote expression of the Th2 immune response phenotype that has
been associated with asthma and allergic disease. Many kinds of cytokines stimulate B
cells and T cell switching to the Th2 subtype, attract and prolong the infiltration and
survival of eosinophils, and increase local IgE production, resulting in allergic or
asthmatic response. IL-4, for example, is a Th2 cytokine which induces isotype switching
of B cells in antibody production from IgM to IgE. IL-5, on the other hand, is important
for the proliferation and activation of eosinophils after exposure to some types of
allergens such as pollen and OVA (Miyabara et al., 1998). In a study by Diaz-Sanchez et
al. (1996), healthy, nonsmoking human volunteers were exposed to DEP and mRNA
expression for cytokines in nasal lavage was examined. Before challenge, most
individuals had detectable mRNA levels of only a few cytokines (IFN-γ, IL-2 and IL-13).
However, after challenge with 0.3 mg DEP, these three cytokines and a number of
additional kinds (IL-4, IL-5, IL-6 and IL-10) were measured in increasing levels (DiazSanchez et al., 1996). Furthermore, DEP have been shown to enhance Th2 cytokine
production more efficiently when combined with an allergen than exposure to an allergen
or DEP alone. Exposure of mice to DEP with OVA markedly increased local IL-4 and
IL-5 levels compared with either antigen or DEP alone (Takano et al., 1997). In a human
study, Diaz-Sanchez et al. (1997) also showed that healthy human individuals exposed to
DEP together with ragweed antigen had higher levels of IL-5 production in nasal lavage
fluid than those exposed to DEP alone.

27

One of the important effects of DEP on modulation of the immune responses is
thought to increase IgE synthesis, thus facilitating allergic sensitization in atopic subjects
and the subsequent development of clinical respiratory symptoms. IgE is produced by
activated B cells in response to a specific allergen. Once produced IgE attaches to mast
cells and, when cross-linked by allergen, induces mast cells to release histamine and
leukotrienes. The chemicals released from mast cells cause constriction of bronchial
smooth muscle, mucus secretion, and serum leakage into the airways and result in acute
asthma symptoms (Busse, 2001). The mast cell is often considered the central cell type in
the acute asthmatic response, and IgE is the critical immunoglobulin driving the mast cell
response. Extensive studies have been conducted to demonstrate that DEP, the organic
compounds of DEP, as well as other physical particles may enhance IgE production,
either alone or acting as an adjuvant to allergens (Takafuji et al., 1987; Takenaka et al.,
1995, Diaz-Sanchez et al., 1996; Takano et al., 1997; Dong et al., 2005a, 2005b). It has
been suggested that DEP may enhance IgE production by activating B cells through
inducing Th2 cytokines. One study showed that when human B cell was stimulated by
IL-4, the IgE production was significantly increased after exposure to phenanthrene, a
major polyaromatic hydrocarbon and one of the most important DEP components (Tsien
et al., 1997).

While DEP enhance the Th2 responses to allergic sensitization, the same particles
have been also shown to suppress the host defense mechanism against bacterial infection,
which may contribute to the etiology of air pollution-associated pulmonary diseases such
as infections of the upper and lower respiratory tract. Animal studies conducted in our
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laboratory consistently demonstrate that DEP exposure suppresses both the innate,
orchestrated by alveolar macrophages (AM), and T-cell mediated immune responses,
resulting in an increased susceptibility of the lung to bacterial infection (Yang et al, 2001;
Yin et al., 2002, 2003, 2004a, 2004b, 2005). DEP were shown to inhibit L.
monocytogenes-induced AM production of IL-1β and tumor necrosis factor (TNF)-α,
which are responsible for the innate immunity, and IL-12, which initiates the
development of Th1 responses, but enhance L. monocytogenes-induced AM production
of IL-10, which prolongs survival of the bacteria in these phagocytes. On the other hand,
DEP exposure also suppressed the development of bacteria-specific lymphocytes from
lung-draining lymph nodes, as indicated by the decreased numbers of T lymphocytes and
their CD4+ and CD8+ subsets. Cytokine production by lymphocytes from DEP-exposed
and L. monocytogenes-infected rats showed a marked decrease in the production of IL-2
and IFN-γ compared to bacterial infection alone, suggesting that either DEP inhibit the
production of cytokines by lymphocytes or these lymphocytes contained T cell subsets
that are different from those of bacterial infection alone and less effective in mediating
Th1 immune responses (Yin et al., 2003, 2004a, 2005). In vitro studies further showed
that DEP or organic extracts of DEP, but not washed DEP or CB, dose-dependently
suppressed L. monocytogenes-induced secretion of TNF-α, IL-1β, IL-12 by AM and IL-2
and IFN-γ by lymphocytes obtained from L. monocytogenes-infected rats, but augmented
the AM secretion of IL-10. Parallel to the alterations in cytokine secretion, DEP or
organic extracts of DEP, but not washed DEP or CB, significantly decreased the
phagocytotic and bacterial killing activities of rat AM (Yin et al., 2006). These results
provide direct evidence that DEP, through the actions of organic components, suppresses
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AM immune functions against bacterial infection. Inhibition of AM phagocytic function
and alterations of AM and lymphocyte cytokine secretion by DEP and DEP organic
compounds may be implicated in the diminished AM bactericidal activity and the
lymphatic arm of the host immune system, thus resulting in an suppressed pulmonary
clearance of pathogens and increased susceptibility of the lung to infection.

Biomarker Studies

In recent years, studies have been carried out that have led to the discovery of
biological and biochemical markers, which are increasingly valuable for predicting and
preventing diseases with environmental etiology, including biomarkers of exposure,
effect, and susceptibility for DE. In most of the human biomarkers studies, DNA from
peripheral blood/leukocytes or other cells/tissues are used to evaluate the genotoxicity of
DE exposure. Pohjola et al. (2003) have examined diesel-derived PAH binding to DNA
and compared the differences in DNA adduct forming capacity of diesel- and gasolinederived PAH in human bronchial epithelial cells. The levels of DNA adducts were in
good accord with the 10 DNA adduct-forming PAH concentrations analyzed in the
extracts of particulates form both exhausts. SRM 1650, a standard material for DEP,
dose-dependently formed DNA adducts in the cells, which was about 11- and 31-fold
more than gasoline engine exhaust, when PAH-DNA adduct levels were calculated on an
emission basis (adducts/mg PM/km) (Pohjola et al., 2003). Studies have also shown an
increased formation of 8-hydroxy-2'-deoxyguanosine (8-OHdG) in peripheral blood
lymphocytes and altered antioxidant capacities in serum and red blood cells of coal
miners (Schins et al., 1995, 1999). Kuusimaki et al. (2004) have assessed and evaluated
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the biomarkers of exposure to DE in bus-garage and waste-collection workers. In the
seven measured urinary PAH metabolites including 2-naphthol, 1-hydroxyphenanthrene,
2-hydroxyphenanthrene, 3-hydroxyphenanthrene, 4-hydroxyphenanthrene, 9hydroxyphenanthrene and 1-hydroxypyrene (1-OH-P), the concentrations of 1-OH-P and
2-naphthol and the sum of seven urinary PAH metabolites were higher in the exposed
group than in the control group. In addition, increased O(6)-alkylguanine DNA adducts
were detected in the white blood cells of underground workers, suggesting higher
exposure to nitroso-compounds (Scheepers et al., 2002).

Xenobiotic metabolizing enzymes, especially cytochrome P450 (CYP) 1A1 and
GSTM1, are involved in the activation and conjugation of PAHs and are controlled by
polymorphic genes. In the biomarker of susceptibility studies, Adonis et al. (2003)
therefore connected DE exposure with CYP1A1 and GSTM1 and studied the contribution
of CYP1A1 and GSTM1 polymorphisms on 1-OH-P urinary levels used as the PAH
exposure biomarker. They studied 59 diesel exposed (38 diesel revision workers and 21
subjects working in an urban area as established street vendors) and 44 non-exposed
subjects living in a rural area. When 1-OH-P levels were related with genotypes, an
association was observed for the CYP1A1 2A genotype, so that the diesel-exposed
workers carrying the CYP1A1 2A allele showed significantly higher 1-OH-P levels than
the subjects from the rural area with the same genotype. On the other hand, there was no
significant correlation between urinary 1-OH-P levels and GSTM1 null genotype,
although higher levels of the urinary metabolite were found in individuals carrying the
combined CYP1A1 2A and GSTM1 null genotype. These results suggested an
association between levels of the exposure biomarker 1-OH-P and presence of the
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CYP1A1 2A genotype, a potential genetic susceptibility biomarker which might be useful
in identifying individuals at higher risk among people exposed to high PAH levels in DE.

Since benzene, a component of DE, causes alterations in porphyrin metabolism, and
some of these may lead to the formation of tumors, heme synthesis is proposed as a
biomarker of early health effects of DE. Muzyka et al. (2002) have investigated the levels
of 5-aminolevulinic acid (ALA) and protoporphyrin (PP), activities of ALA synthase and
ferrochelatase, as well as levels of PP associated with DNA (PP/DNA) in lymphocytes
from workers exposed to DE at a marine diesel fuel terminal. Levels of ALA, PP, and
ALA-synthase activity were significantly increased in marine terminal workers. At the
same time ferrochelatase activity was decreased compared to unexposed controls. In an
investigation carried out at a coal mine and at an oil-shale mine, Muzyka et al. (2003,
2004) reported that the values of PP and PP/DNA in lymphocytes appeared to be
significantly increased only in miners in the oil-shale mine. There was no difference in
the levels of PP and PP/DNA and ferrochelatase activity between surface workers and
miners at the coal mine. The level of heme in lymphocytes of coal mine miners was
significantly higher than in miners of the oil-shale mine. The activity of ferrochelatase
was significantly lower in underground workers compared to surface workers at this
mine. These studies suggested that alterations of porphyrin and heme metabolism in
peripheral lymphocytes might serve as biomarker in assessment of exposure to DE
effects. In addition, Knudsen et al. (2005) have shown that DNA damage in frozen blood
samples was significantly higher in underground workers driving diesel-powered
excavation machines than surface workers.
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Mechanisms of DEP-Induced Pulmonary Responses

Although extensive studies have been conducted, the mechanisms by which DE
exerts its adverse health effects have not yet been fully understood. This may be at least
partially due to the complex physical and chemical features of DE composition.
However, emerging data suggest a key role for DEP-induced oxidative stress in their
health effects. DEP or the organic DEP components have been shown to induce
production of ROS in a variety of cell types, which have been involved in the
pathogenesis and development of many different health conditions and are likely to be
responsible for the adverse effects of DEP on the cardiopulmonary system, including
lung cancer, asthma, COPD, and cardiovascular diseases. This review, rather than
attempting to review all available data on mechanistic studies, highlights those that aid
our understanding of the role of ROS in DE-induced adverse effects.

Studies have shown that the particulate component of DEP elicits respiratory burst
activity of inflammatory cells, such as AM and neutrophils in the production of ROS and
proinflammatory cytokines. The organic components of DEP, such as PAHs and
quinones, on the other hand, have been shown to produce intracellular ROS in AM
through interaction with metabolizing enzymes such as CYP1A1 (Ma and Ma, 2002;
Baulig et al., 2003; Yin et al., 2004b). PAHs are converted to quinones via
biotransformation involving CYP1A1, expoxide hydrolase, and dihydrodiol
dehydrogenase (Penning et al., 1999). Quinones act as catalysts to produce ROS and may
be key compounds in PM toxicity along with transition metals (Penning et al., 1999;
Monks et al., 1992). Redox cycling of quinones undergoes one-electron reductions by
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NADPH cytochrome P450 reductase to form semiquinones (Monks et al., 1992), which
can be recycled to the original quinones, leading to the formation of superoxide.
Transition metals, such as Fe, Ni, Cu, Co and Cr are also important in ROS generation
through the Fenton and Haber-Weiss reactions (Kehrer et al., 2000). It is possible that
transition metals may synergize with organic PM components in ROS generation (Stearns
et al., 2002).

An imbalance between the production of ROS and antioxidant capacity leads to a
state of oxidative stress that contributes to the pathogenesis of a number of human
diseases including those of the lung by damaging lipids, protein, and DNA. The
genotoxicity of DEP may be mediated by ROS, although it may be caused by direct
(primary) actions of PAHs, which are known to be genotoxic in vivo and capable of
forming DNA adducts (Tsurudome et al., 1999; Arlt et al., 2001). Indeed, ROS has been
shown to be genotoxic and proliferating substances that lead to tumor formation
(Oberdorster, 1995; Oberdorster, 1997; Borm et al., 1996; Morrow et al, 1996). ROS are
able to induce oxidation of DNA bases, DNA strand breaks, or lipid peroxidationmediated DNA adducts (Kasai et al, 1986; Schraufstatter et al., 1988; Aruoma et al.,
1989; Trush et al., 1991). In vivo studies have shown that the 8-hydroxyguanine levels in
rat lung DNA increased markedly at an early phase after DEP exposure, by the
generation of ROS and the inhibition of 8-hydroxyguanine repair activity (Tsurudome et
al., 1999). These studies indicated that the ROS produced after DEP exposure may play
an important role in the genotoxicity and carcinogenicity of DEP.
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An important mechanism of DEP mediated pulmonary responses involves the
generation of ROS and depletion of the antioxidant capacity in lung cells. Li et al. (2002)
demonstrated that the organic DEP extract induces a stratified oxidative stress response,
leading to heme oxygenase 1 (HO-1) expression at normal reduced
glutathione/glutathione disulfide (GSH/GSSG) ratios and that the activation of Jun kinase
and IL-8 production at intermediary oxidative stress levels culminated in cellular
apoptosis in parallel with a sharp decline in GSH/GSSG ratios. Whitekus et al. (2002)
also showed that DEP induced an oxidative stress as indicated by a decrease in
intracellular GSH/GSSG ratios and protein and lipid oxidation in vitro, which could be
blocked by the thiol antioxidants, bucillamine (BUC) and N-acetylcysteine (NAC). They
further demonstrated that NAC and BUC effectively inhibited the generation of lipid
peroxidation and protein oxidation in the lungs and the adjuvant effects of DEP in the
induction of OVA-specific IgE and IgG1 production in OVA- plus DEP-exposed
animals. These results showed that DEP may alter allergic responses, which are at least
partially, attributed to the DEP-induced oxidative stress in AM and epithelial lung cells.

In fact, ROS has been implicated in the etiology and pathogenesis of allergic asthma.
ROS can reproduce many of the athophysiological features of asthma including enhanced
arachidonic acid release, airway smooth muscle contraction, increased airway reactivity
and secretions, increased vascular permeability, and increased synthesis of
chemoattractants Owen et al., 1991; Sadeghi-Hashjin et al., 1996). ROS-mediated injury
to the epithelium produces hyperresponsiveness of human peripheral airways, suggesting
that ROS may play a role in the pathogenesis of asthma (Hulsmann et al., 1994).
Neutrophils isolated from peripheral blood of asthmatic patients can generate greater
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amounts of superoxide and H2O2, and their ability to produce superoxide correlates with
the degree of airway hyperresponsiveness to inhaled methacholine (Seltzer et al., 1986;
Hiltermann et al., 1998). Inflammatory cells obtained from asthmatic patients,
particularly eosinophils, which produce more superoxide than neutrophils or
macrophages, release ROS at baseline and after stimulation ex vivo (Sedgwick et al.,
1990; Sanders et al., 1995). This suggests that the biochemical milieu in asthma contains
factors which may prime ROS generation in vivo. Eosinophils play a critical role in
asthma because their increased presence in BAL fluid and blood is closely linked with
bronchial hyperresponsiveness (Foreman et al., 1999; Wood et al., 2000). BAL fluid
eosinophils, AM, and neutrophils from asthmatic patients produce more ROS than do
those from normal subjects (Teramoto et al., 1996; Schauer et al., 1991). ROS directly
contract airway smooth muscle preparations and this effect is enhanced when the
epithelium is injured or removed. This observation might provide a mechanistic link
between epithelial injury arising from a variety of causes and airway hyperresponsiveness
(Hulsmann et al., 1994). ROS also appear to directly stimulate histamine release from
mast cells and mucus secretion from airway epithelial cells (Krishna et al., 1998). In
addition, there is also increasing evidence showing that oxidative stress has been
proposed in the pathogenesis of many other conditions such as pulmonary infection,
COPD and cardiovascular diseases (Yin et al., 2004b; Langen et al., 2003; Rahman,
2005; Tao et al., 2003; Hirano et al., 2003). For example, Yin et al. (2004b) have shown
the role of ROS in modulation of the AM-mediated immune responses to L.
monocytogenes by DEP. Exposure of L. monocytogenes-infected AM to DEP or their
organic extracts resulted in an increased expression of intracellular ROS and HO-1,
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followed by an increased secretion of IL-10 but decreased secretion of TNF-α and IL-12
from the cells. Interestingly, direct stimulation of the AM with pyrogallol, a superoxide
donor, up-regulated HO-1 and IL-10 but decreased secretion of IL-12. This study
provides direct evidence that DEP mediated ROS response exerts a modulating effect on
immune responses against bacterial infection, causing a switch of immune response from
Th1 to Th2, thereby enhances both respiratory infection and allergic asthma.

At least two well-known classes of transcription factors, the nuclear factor-κB (NFκB) and the activator protein-1 (AP-1) families, are regulated by the intracellular redox
state (Pinkus et al., 1996). Expression of cytokine genes is controlled by transcription
factors, which interact with specific sequence motifs in the promoter region of the gene.
Particularly, NF-κB plays a key role in regulation of the expression of various genes
involved in the inflammatory and immune response (Jany et al., 1995). NF-κB activation
requires cytosol dissociation of the inhibitory subunit IκB from the NF-κB protein
complex, allowing its nuclear translocation and binding to DNA consensus sites. A
particular IκB-α kinase complex phosphorylates IκB, resulting in its rapid ubiquitation
and subsequent degradation by the proteasome (Zandi et al., 1997).

Studies have shown that DEP activate several signaling pathways, such as mitogenactivated protein kinases (MAPK) and transcription factors, in particular NF-κB in
human bronchial epithelial cells (Hashimoto et al., 1999; Marano et al., 2002; Takizawa
et al., 2003). Electronphoresis mobility assays have shown that DEP exposure may
enhance the binding of NF-κB to DNA in airway epithelial cells (Baeza-Squiban, 1999;
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Takizawa et al., 1999). Furthermore, transient transfection experiments with a construct
containing NF-κB binding DNA consensus sites concluded that DEP might induce the
activation of NF-κB-dependent gene transcription (Takizawa et al., 1999). Although no
data exist for the activation of AP-1 by DEP, evidence showed that β-naphthoflavone (βNAF), a prototype of PAH, and a derivative tert-butylhydroxyquinone (tBHQ), a
prototype quinone, might induce AP-1 electrophoretic mobility shift complexes in
macrophage cell lines (Ng et al., 1998). Ng et al. reported that β-NAF and tBHQ induced
the activity of the N-terminal jun kinase (JNK) MAPK cascade. This cascade, which is
involved in the transcriptional activation and expression of c-Jun and serves to regulate
different aspects of AP-1 transcriptional activity, can be induced by various kinds of
injurious chemicals and cellular stress inducers, including genotoxic chemicals,
inflammatory cytokines, and H2O2 (Kyriakis et al., 1994). These data indicated that DEP
and DEP-derived PAHs and their quinone derivatives could induce the activation of
MAPK cascades as well as transcription factors NF-κB and AP-1. These effects were
also dependent on the role of ROS. Studies have shown that the release of DEP-induced
cytokines and the activation of MAPK and NF-kB were significantly inhibited by
antioxidants (such as NAC), indicating that ROS was strongly incriminated in these DEP
effects (Hashimoto et al., 2000; Marano et al., 2002; Baulig et al., 2003; Takizawa et al.,
2003).

In addition to the adjuvant effect, DEP can also induce IgE production by acting
directly on B cells. Takenaka et al. (1995) demonstrated that the organic DEP extract of
PAHs enhanced human IgE production from purified B cells. Additionally, the pattern of
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mRNAs coding for distinct isoforms of the ε chain was altered by PAH-DEP, and B-cell
expression of the low-affinity IgE receptor was upregulated by PAH-DEP. Studies by
other investigators have also indicated that the organic extract of DEP (PAH-DEP) and
particularly, phenanthrene, a major component of DEP, consistently enhanced IgE
production by 2C4/F3, a human Epstein-Barr virus transformed isotype switched , IgE
producing B cell line (Tsien et al., 1997). Enhanced IgE production in the human airway,
resulting from exposure to PAH-DEP, may be an important factor in the increase in
airway allergic disease.

2.5 Summary

Ample studies have indicated that DE, at levels occurring in both ambient and
occupational settings, exerts adverse health effects on humans. There is a general
agreement in the scientific community that exposure to relatively high levels of DE are
likely to cause lung cancer in humans, although contradiction exists which challenge the
notion that DE is a probable human carcinogen (Bunn et al., 2002, 2004; Hesterberg et
al., 2005). DEP exposure is also associated with a number of non-specific lung diseases
including pulmonary bacterial infection and allergic asthma.

Epidemiology data further linked DE exposure with excess risk for respiratory
symptoms, reduced lung function, COPD, and cardiovascular diseases in humans. Both
the organic and particulate components of DEP have been shown to play a role in
modulating the immune inflammatory responses and the induction of genotoxicity.
Allergic asthma is a complex disease which involves B cell production of allergen-
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specific antibodies that leads to eosinophil infiltration and airway inflammation resulting
in obstructive airway disease through enhanced Th2 immunity.

The production of ROS by lung cells (including AM and type II cells) which result in
oxidative stress is considered a key factor responsible for the adverse DEP effects. The
literature suggests that DEP may alter pulmonary immune responses through multiple
pathways that include enhanced Th2 immunity, induction of airway inflammation
through direct effect on epithelial cells, and systemic effect on B cell responses. Because
of the multiple pathways, it is likely that the relative timing of DEP exposure and allergen
sensitization may play a role in DEP-mediated allergic asthma.
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3. MATERIALS AND METHODS
3.1 Animals and Exposure Schedule

Male Brown Norway rats [BN/CrlBR] weighing 200-225 g were obtained from
Charles River Laboratories (Wilmington, MA). The animals were housed in a clean-air
and virus-free room with restricted access, given a conventional laboratory diet and tap
water ad libitum, and allowed to acclimate for 1 week before use in an animal facility
approved by the Association for Assessment and Accreditation of Laboratory Animal
Care.

OVA Immunization.

A solution of OVA (Grade V, Sigma Chemical Co., St. Louis, MO) in endotoxin-free
saline (1%) was aerosolized using a DeVilbiss-646 nebulizer (DeVilbiss, Somerset, PA).
To achieve the desired concentration, filtered air was passed through the nebulizer and
used as a diluent for the aerosolized OVA. The concentration of OVA in the chamber was
determined by collecting samples onto 0.4 µm filters (Polycarbonate Membrane, Poretics
Corporation, Livermore, CA) from a chamber side port at a rate of 1 l/min. Filters were
washed with 10 ml of endotoxin-free saline and analyzed for protein using the Coomassie
blue dye reagent (Bio-Rad Laboratories, Hercules, CA). Rats were sensitized to OVA at
an average chamber concentration of 42.3 ± 5.7 mg/m3 for 30 min on days 1, 8, and 15,
and challenged with OVA on day 29 (protocol A). The animals were subjected to wholebody plethysmography on day 30, 24 h after the last OVA dose, and they were sacrificed
on day 31 for biochemical and cellular measurements (protocol B). Nonsensitized
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animals were exposed to aerosolized endotoxin-free saline following the same exposure
schedule.

DEP Exposure.

a. Protocol A and B.

A standardized DEP sample (standard reference material 2975), representing heavyduty diesel engine with a mass median aerodynamic diameter of 0.5 µm, was purchased
from the National Institute of Standards and Technology (Gaithersburg, MD). Diesel
exhaust particles were suspended in endotoxin-free sterile saline (Baxter Healthcare
Corporation, Deerfield, IL), followed by sonication for 2 min in an ultrasonic processor
with a micro tip (Heat System-Ultrasonics, Plainview, NY) prior to use. The DEP
inhalation exposure system used in this study has been described and characterized
elsewhere (Yin et al., 2002, 2004a). Rats were exposed to either filtered air or DEP (22.7
± 2.5 mg/m3), 4 h/day for 5 consecutive days either prior to the sensitization from day -4
to day 0 (protocol A) or on days 24-28 of the sensitization process (protocol B), 24 h
prior to the last (challenge) dose of OVA using a nose-only directed flow exposure unit
(CH Technologies, Inc., Westwood, NJ). The DEP concentration in the exposure unit was
monitored by both gravimetric sampling of dust collected on a polycarbonate membrane
filter (37 mm, 0.45 µm, Poretics Corporation, Livermore, CA) at a sampling rate of 1
l/min, and with a Grimm Model 1.108 portable dust monitor (GRIMM Technologies,
Inc., Douglasville, GA), which allows continuous measurement of the particle
concentration in the exposure unit in real time. The estimated mean lung deposition of
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DEP for the above-described inhalation exposure, calculated based on the method of
Leong et al. (1998), was 402 ± 58 µg/rat.

The exposure groups (5 rats/group) for the present study were: nonsensitized/ airexposed/saline challenged (saline + air); non-sensitized/DEP exposed/ saline challenged
(saline + DEP); OVA-sensitized/air-exposed/OVA challenged (OVA + air); and OVAsensitized/DEP-exposed/OVA challenged (OVA + DEP). All parameters were measured
after saline/OVA challenge (the last dose) with and without DEP exposure.

b. DEP by Intratracheally Instillation (i.t.)

Rats were anesthetized with sodium methohexital (35mg/kg intraperitoneally) and
placed on an inclined restraint board. A 0.3-ml suspension of DEP at a dose of 35mg/Kg
body weight, or equivalent amount of saline (control) was intratracheally instilled. Rats
were sacrificed 3 days postexposure.

LPS Treatment.

A solution of lipopolysaccharide (LPS) (Sigma Chemical Co., St. Louis, MO) in
sterile water (0.5mg/Kg) was intraperitoneally injected to the rats. The rats were
sacrificed 2 hours after LPS treatment.

3.2 Bronchoalveolar Lavage (BAL) and Determination of BAL Markers

BAL.
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Rats were deeply anesthetized with an overdose of sodium pentobarbital (200 mg/kg,
ip; Butler, Columbus, OH) and euthanized by exsanguination via the vena cava. After
clamping off the right apical lobe, the trachea was cannulated and the remaining lung
lobes were first lavaged with 6 ml Ca2+/Mg2+-free phosphate buffered solution (PBS, 145
mM NaCl, 5 mM KCl, 1.9 mM NaH2PO4, 9.35 mM Na2HPO4, and 5.5 mM glucose; pH
7.4). The first BAL fluid sample was centrifuged at 500 × g for 10 min at 4°C, and the
resultant cell-free supernatant (~ 4 ml/rat) was analyzed for various biochemical
parameters. The lungs were further lavaged with 6 ml aliquots of PBS until 80 ml of BAL
fluid was collected. These samples were also centrifuged for 10 min at 500 × g, and the
cell-free BAL fluid discarded. The cell pellets from all washes for each rat were
combined, washed, and resuspended in PBS and evaluated as described below.

BAL Cell Differentiation.

The BAL cells were numerated couted using a CoulterMultisizer II and AccuComp
software (Coulter Electronics, Hialeah, FL). Cell suspensions (5 × 104 cells) were
centrifuged for 5 min at 800 rpm and pelleted onto a slide using a Cytospin centrifuge
(Shandon Life Sciences International, Cheshire, England). Three hundred cells per rat
were identified and differentiated after labeling with Leukostat stain (Fisher Scientific,
Pittsburgh, PA). The absolute numbers of cells differentiated were calculated by
multiplying the total number of cells by the percentage of the total within each cell type.

Albumin and LDH.
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The albumin content, which indicates injury to the bronchoalveolar-capillary barrier,
and LDH activity, which indicates cytotoxicity, were determined in the first fraction of
acellular BAL fluid, using a COBAS MIRA auto-analyzer (Roche Diagnostic Systems,
Montclair, NJ). Albumin content was determined colorimetrically at 628 nm based on
albumin binding to bromcresol green using an albumin BCG diagnostic kit (Sigma).
Lactate dehydrogenase activity was determined by measuring the oxidation of lactate to
pyruvate coupled with the formation of reduced form of nicotinamide adenine
dinucleotide at 340 nm using the Roche Diagnostic reagents and procedures (Roche
Diagnostic Systems, Indianapolis, IN).

Chemiluminescence (CL).

The light generation as CL by resting or stimulated AM as a result of ROS production
was determined in a total volume of 0.5 ml HEPES buffer. Resting CL was determined
by incubating BAL cells containing 0.5 × 106 AM at 37°C for 10 min in 0.008 % (w/v)
luminol (Sigma) followed by the measurement of CL for 15 min. Luminol was used as an
amplifier to enhance detection of the light and was first dissolved in a small amount of
ethanol before being brought up to its final concentration in HEPES buffer. To determine
zymosan-stimulated CL, unopsonized zymosan (2 mg/ml, Sigma) was added immediately
prior to the measurement of CL. Measurement of CL was performed with an automated
Berthold Autolumat LB 953 luminometer (Wallace, Inc., Gaithersburg, MD) for 15 min,
and the integral of counts versus time was calculated. Zymosan-stimulated CL was
calculated as the total counts of stimulated cells minus the total counts of the
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corresponding resting cells. The zymosan-stimulated CL was attributed to AM only, as
rat neutrophils do not respond to unopsonized zymosan in this system.

NO Production.

The production of NO by AM was determined as follows. Cells were suspended in
Eagle’s minimum essential medium (MEM, Biowhittaker, Walkersville, MD)
supplemented with 1 mM glutamine, 100 µg/ml streptomycin, 100 units/ml penicillin,
and 10% heat-inactivated fetal bovine serum (FBS). Aliquots of 1 ml cell suspension
containing 2 × 106 AM were incubated in a humidified incubator (37°C and 5% CO2) for
2 h to allow cell attachment to the culture plate. The non-adherent BAL cells were
removed by rinsing the monolayer three times with culture medium. The remaining AMenriched cells were incubated in 1 ml medium for 24 h at 37°C and 5% CO2. The level of
nitrite produced from NO in the AM-conditioned media was measured colorimetrically
with the Greiss reaction using sodium nitrite as a standard (Green et al., 1982). The levels
of NO in the first fraction of acellular BAL fluids were also determined using the Greiss
assay.

Western Blot Analysis.

The recovered AM-enriched cells were washed with PBS and then suspended in 100
µl of a lysis buffer (50 mM Tris-HCl, 1% NP-40, 2 mM EDTA, 100 mM NaCl, 20 µg/ml
aprotinin, 20 µg/ml leupeptin, 1 mM phenylmethylsulfonyl fluoride; pH 7.5) and left on
ice for 10 min. Cytoplasmic extracts were separated from the nuclei by centrifugation at
14,000 rpm for 10 min at 4°C, and protein content determined using a BCA Protein
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Assay Kit (Pierce, Rockford, IL). An equal amount of protein (30 µg / well) for each
sample was boiled for 5 min, loaded, and run for electrophoresis in a 4-20% Tris-Glycine
gel (Invitrogen, Carlsbad, CA) at 125 V. The gel was transferred electrophoretically (BioRad Laboratories, Hercules, CA) to a nitrocellulose membrane (Schleicher & Schuell,
Keene, NH), and the blots were blocked with 5% milk in TBST buffer (20 mM Tris-HCl,
100 mM NaCl, 0.1% Tween 20; pH 7.5) for 1 h at room temperature. Membranes were
then probed with a polyclonal rabbit antibody against inducible NO synthase (iNOS) and
a horseradish peroxidase-conjugated anti-rabbit IgG (Santa Cruz Biotechnology, Santa
Cruz, CA). Blots were developed using commercially developed enhanced
chemiluminescence reagent (Amersham Biosciences, Piscataway, NJ). For quantification,
bands in photographs were scanned by a densitometer linked to a computer system
(Personal Densitometer SI, Amersham Biosciences, Piscataway, NJ).

3.3 Analysis of Lymphocytes from Lung-Draining Lymph Nodes (LDLN)

Isolation of Lymphocytes.

Lymphocytes were isolated from LDLN as described previously (Yin et al., 2003).
Briefly, LDLN were excised from each rat after BAL, teased apart, and homogenized
with a glass pestle in a screen cup (Sigma). Single cell suspensions were obtained by
passing the cell clumps through a 22-gauge needle attached to a 10-ml syringe, and
washed twice with PBS. Lymphocytes were isolated by Histopaque (density 1.083;
Sigma) gradient centrifugation. Samples were centrifuged for 30 min at 2500 rpm, and
lymphocytes were collected, washed, re-suspended in 1 ml of PBS, and counted using a
standard hemocytometer. The cell samples thus prepared showed predominance of
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lymphocytes and cell viability of greater than 98% as determined by the trypan blue
exclusion technique.

Flow Cytometric Analysis.

The effects of OVA and/or DEP exposures on frequencies of T cell subsets in LDLN,
i.e., the expression of CD3, CD4, and CD8 cell surface markers, were examined with a
flow cytometric method described elsewhere (Yin et al., 2003). Lymphocytes (106 cells)
were stained with the addition of FITC-labeled conjugated antibodies against these cell
surface markers (BD Pharmingen, San Diego, CA). The flow cytometric data were
collected with a Becton-Dickinson FACScan using FACScan Research Software
(Becton-Dickinson Immunocytometry System) and analyzed using the PC-LYSYS
software (Becton-Dickinson).

3.4 Cytokine Production.

The BAL cells were suspended in Eagle’s minimum essential medium (MEM,
Biowhittaker, Walkersville, MD) supplemented with 1 mM glutamine, 100 µg/ml
streptomycin, 100 units/ml penicillin, and 10% heat-inactivated fetal bovine serum.
Aliquots of 1 ml cell suspensions, adjusted to contain 2×106 AM, were added to each
well of a 24-well tissue culture plate and incubated in a humidified incubator (37°C and
5% CO2) for 2 h to allow cell attachment to the culture plate. The nonadherent BAL cells
were then removed by rinsing the monolayer three times with culture medium. The
remaining AM-enriched cells or lymphocytes (2 × 106) isolated from LDLN were then
incubated in 1 ml medium at 37°C and 5% CO2 for 24 h. The AM- or lymphocyte-
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conditioned media were collected, centrifuged (1200 × g for 4 min), and aliquots of the
supernatants were stored at -70°C until assayed.

The production of IL-10 in AM-conditioned media under various exposure conditions
was quantified by the enzyme-linked immunosorbent assay (ELISA) using the OptEIA
ELISA Sets (BD PharMingen) as previously described (Yin et al., 2004a). The levels of
IL-12 in the AM-conditioned media and IL-4 and interferon (IFN)- γ in the lymphocyteconditioned media and serum were quantified by ELISA using commercial ELISA kits
(BioSource International, Inc., Camarillo, CA). The range of detection was: 7.8–500
pg/ml for IL-4 and IL-12, 15.6–1000 pg/ml for IL-10, and 31.3–2000 pg/ml for IFN-γ.

The levels of IL-10, IL-6, and IL-1β in blood samples from saline, DEP (by i.t) and
LPS (by i.p) treated rats were measured by ELISA using commercial ELISA kits
(BioSource International, Inc., Camarillo, CA).

3.5 Determination of Intracellular GSH
Alveolar macrophages or lymphocytes (2×105 cells) were plated in 96-well
microplates, washed twice with PBS, and lysed with 240 µl of a cold lysing buffer (0.1%
triton X-100 in 0.1 M sodium phosphate buffer, 5 mM EDTA, pH 7.5). The lysates were
acidified with 0.1 N HCl (12 µl) and protein precipitated with 50% sulfosalicyclic acid
(12 µl) followed by centrifugation at 4°C. Samples of the supernatants were assayed for
total GSH according to the method of Buchmuller-Rouiller et al. (1995). Briefly, 50 µl of
cell supernatants or GSH standards were distributed to each well of a 96-well microplate,
followed by 50 µl of 2.4 mM 5,5'-dithio-bis(2-nitrobenzoic acid). After the mixture was
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incubated at room temperature for 10 min, 50 µl each of NADPH (0.667 mg/ml) and
glutathione reductase (40µg/ml) were added. The results of the GSH-specific reaction
were monitored by OD readings at 405 nm every minute for 8 min with a Spectramax
250 plate spectrophotometer using Softmax Pro 2.6 software (Molecular Devices Corp.,
Sunnyvale, CA). One of the OD readings obtained with the most satisfied standard curve
was selected as the final result.

3.6 Determination of OVA-Specific IgE and IgG from Blood Serum

Blood samples were collected during exsanguination from the vena cava of rats at
sacrifice. The sera dilutions with 5% horse serum albumin (HOSA)/PBS of 1/50 were
analyzed for OVA-specific IgE and IgG. Diluted sera (100 µl) were added to a 96-well
plate (ICN Biomedicals, Horsham, PA) that had been previously coated with 200 µl of
1% OVA carbonate coating buffer and blocked with a 5% HOSA/coating buffer
according to the method of Voller and Bidwell (1986). The plates were incubated
overnight at 4°C and subsequently incubated with sheep anti-rat IgE (100 µl, 1:2500
dilution in HOSA/PBS, ICN Biomedicals, Costa Mesa, CA) which, according to
manufacturer provided information, is specific for IgE class and does not cross-react with
the other Ig classes, including IgG. The plates were then incubated with horseradish
peroxidase-bound donkey anti-sheep IgG (100 µl, 1:5000 dilution in HOSA/ PBS, ICN
Biomedicals) for 2 h each at room temperature. The plates were washed 3 times after
each incubation, treated with tetramethylbenzidine (Sigma), and read at 630 nm.
Ovalbumin-specific IgG was determined using goat anti-rat IgG (1:500 dilution in
HOSA/PBS, Sigma) and peroxidase-labeled rabbit anti-goat IgG (1:12,500 dilution in
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HOSA/PBS, Sigma) as detection antibodies, following the same protocol described
above. The serum from one animal exposed to OVA was assigned a value of 100 and
used as a reference to obtain relative concentrations for the OVA-specific IgE and IgG in
serum samples from each group.

3.7 Analysis of Alveolar Type II (ATII) Cells

Isolation of ATII Cells.

Type II cells were isolated using a standard protocol (Dobbs et al., 1986). Briefly,
after removal of AM and blood cells, elastase solution (MP Biomedicals, Inc., Irvine,
CA) was instilled via the trachea to dissociate the cells from lung tissue. The lung tissue
was then minced in the presence of DNase I (Sigma) and FBS, and the suspension was
sequentially filtered through nylon mesh. The cell suspension was plated on
bacteriological plastic dishes coated with rat IgG (Sigma). After 1 h at 37°C, the
nonadherent ATII cells were removed from the plate to which AM and other immune
cells were adherent. Cells obtained by this method contained ~ 90% ATII cells and >90%
excluded trypan blue.

Western Blot Analysis.

Expression of iNOS in ATII cells was determined by Western blot analysis using the
same procedures for AM as described above, using cytoplasmic protein (30 µg/well)
extracted from the freshly isolated ATII cells.

Flow Cytometric Analysis for ROS
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Freshly isolated ATII cells (5 × 105 cells) were washed with a washing buffer (PBS
with 2% FBS and 0.02% NaN3, pH 7.4), and re-suspended in DMEM/F12 medium
(Invitrogen, Carlsbad, CA) containing 10 µM of 4,5 diaminofluorescein diacetate (DAF,
Sigma) or 5 µM dihydroethidium (DHE, Molecular Probes, Eugene, OR) at 37°C for 30
min. After washing, the flow cytometric data were immediately collected with a BectonDickinson FACScan using FACScan Research Software (Becton-Dickinson
Immunocytometry System, San Jose, CA), and analyzed using the PC-LYSYS software
(Becton-Dickinson).

3.8 Measurement of Airway Responsiveness

Airway responsiveness was assessed by inducing airflow obstruction with a
methacholine (MCh) aerosol using a noninvasive method (Hamelmann et al., 1997).
Minute volume, tidal volume, breathing frequency, and enhanced pause (Penh) were
obtained from conscious rats placed in a whole-body plethysmograph (Buxco Electronics
Inc., Troy, NY). In this system, rats were unrestrained and tolerated repetitive
measurements. Measurements of MCh responsiveness were obtained by exposing rats for
3 min to aerosolized PBS and incremental doses (6.25-25 mg/ml) of aerosolized MCh
(Sigma) in PBS, and monitoring the breathing pattern for 3 min after each MCh
challenge. The Penh values measured during each 3-min sequence were averaged and
expressed, for each MCh concentration, as a percentage of baseline Penh values observed
after PBS exposure.

3.9 Analysis of B Lymphocytes from Spleens.
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Isolation of B Lymphocytes.

B lymphocytes from rats that had been treated with DEP and saline by i.t. were
isolated from the spleen according to the manufacturer’s protocol as described in the
commercial MagCellect rat B cell isolation kit (R & D Systems, MN). Cells were
cultured in 96 - well round-bottomed microtiter culture plates in PRMI 1640
supplemented with 10% fetal calf serum, 2 mmol/L glutamine, 50 U/ml penicillin, and 50
µg/ml streptomycin. B cells were seeded at 2 x 105 cells in 0.2 ml complete PRMI per
well cocultured with OVA (10mg/ml), IL-4 (10ng/ml) and LPS (10 µg/ml). Cultures were
maintained at 37°C in a 5% atmosphere for 7, 14, 21days, at each time point the
supernatant was collected for IgE measurement.

Determination of OVA- specific IgE.

IgE production by B lymphocytes was measured by the same analysis using the same
procedures as for blood which were described above.

3.10 Immunohistochemistry

Before BAL, the right apical lobe was clamped off to prevent entry of lavage fluid.
Following BAL and excision of LDLN, the clamp was removed and all lobes were
inflated intratracheally with 10% formalin. The right apical lobe was processed within 24
h and embedded in paraffin. Sections were cut at 5 µm, deparaffinized in xylene,
rehydrated, and stained for iNOS expression (Porter et al., 2002). Briefly, microwave
antigen retrieval with citrate buffer (pH 6.0) of rehydrated tissue was performed,
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followed by peroxidase blocking with a 1:1 mixture of 3% H2O2 and methanol. Slides
were incubated overnight at 4°C with iNOS monoclonal antibody (N32020, Transduction
Laboratories, Lexington, KY, 1:50 dilution). Localization was achieved using a
streptavidin-biotinperoxidase system for use on rat specimens (K0609, Dako, Carpinteria,
CA), with diaminobenzidene (Zymed Laboratories, San Francisco, CA) as the
chromogen. Tissues were counterstained with Mayer’s hematoxylin, dehydrated and
covered with a coverslip. Non-stained sections where the primary antibody was omitted
were obtained as negative controls, and sections from rats that had been intratracheally
instilled with lipopolysacchride (LPS, Sigma, 10mg/kg) 24 h prior to sacrifice were
stained for positive controls.

3.11 Statistical Analysis

Results are expressed as means ± standard error (SE). The significance of the
interaction among different treatment groups for different parameters at each time point
was assessed by analysis of variance (ANOVA). The significance of difference between
individual groups was analyzed using the Tukey-Kramer’s Honestly Significant Different
Test. For all analyses, the criterion of significance was set at p < 0.05.
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4. RESULTS
4.1 Results for Protocol A

Lung Inflammation/Injury

The LDH activity and albumin content in the first acellular BAL fluids of rats from
various exposure groups were determined as markers of lung injury and cytotoxicity
(Figure 1), whereas the numbers of recovered AM, Polymorphonuclear neutrophils
(PMNs), lymphocytes, and eosinophils in BAL fluids were counted as an index of airway
inflammation (Figure 2). These data show that both the BAL proteins and inflammatory
cell counts for DEP exposure alone, when measured at 9 and 30 days after exposure,
were not different from those of the air-exposed control, suggesting that DEP exposure
did not cause lung injury at 9 or 30 days post-exposure. Exposure of rats to OVA
(administered weekly at a dose of 40.5 ± 6.3 mg/m3) caused significant increases in
neutrophils, lymphocytes, eosinophils, albumin, and LDH activity in the rat lung after
two exposures (measured at day 9). These increases were further substantiated in rats
receiving 5 OVA exposures (measured at day 30), with a clear increase in total BAL cells
apparent when comparing to that of the air-exposed control. DEP exposure alone did not
induce inflammation but had a strong effect on OVA-induced inflammatory responses.
As shown in Figures 1 and 2, the combined DEP and OVA exposure resulted in a
significant decrease in OVA-induced inflammatory cell infiltration at day 30 and LDH
and albumin at days 9 and 30 of DEP exposure.
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Alveolar Macrophage Function

NO, an important marker of allergic inflammatory responses, in the acellular BAL
fluid (Figure 3) and in AM-conditioned media (Figure 4) from various exposure groups
was determined. The OVA exposure resulted in an increase in NO levels in the acellular
BAL fluid and AM-conditioned media. This increase, however, was significantly
attenuated in rats already exposed to DEP. DEP exposure alone did not affect NO
production in samples obtained at day 9, although the NO levels in the BAL fluid at day
30 showed a moderate decrease comparing to that of the air-exposed controls.

Figure 5 shows the production of IL-10 and IL-12 by AM. DEP exposure had no
significant effect on the production of IL-10 (Figure 5A) or IL-12 (Figure 5B) by AM
recovered from rats 9 and 30 days after exposure. In contrast, OVA sensitization
markedly elevated both IL-10 and IL-12 secretion by AM at both time points. The
production of these cytokines by AM from rats exposed to both DEP and OVA was
significantly lower than cells from rats exposed to OVA alone.

Lymphocyte Population and Cytokine Production
Figure 6 shows the numbers of lymphocytes, T cells, and their CD4+ and CD8+
subsets recovered from LDLN for each exposure group on day 9 (Figure 6A) and day 30
(Figure 6B). DEP exposure was found to increase the numbers of total lymphocytes, T
cells, and their CD4+ and CD8+ subsets in the LDLN compared to the air-exposed
control. Likewise, OVA exposure significantly increased these cell counts on day 9 as
well as on day 30. In the combined DEP and OVA exposure, however, there was a
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significant reduction in total lymphocytes, T cells and CD4+ and CD8+ subsets in the rat
lung on day 30 when compared to data for the OVA-only exposure groups.

Levels of IL-4 and IFN-γ in lymphocyte-conditioned media were below the detection
limit of the ELISA kits used. The effects of DEP and OVA exposure on these cytokines,
therefore, could not be determined.

Intracellular GSH Levels in AM and Lymphocytes

The effect of DEP and OVA exposures on intracellular GSH levels was studied in
AM (Figure 7A) and lymphocytes (Figure 7B) from various exposure groups. DEP
exposure alone slightly decreased GSH levels in AM, but markedly reduced GSH
concentration in lymphocytes on day 9 and day 30. Exposure to OVA significantly
decreased intracellular GSH in both cell types. Under the combined DEP and OVA
exposure, AM and lymphocytes exhibited a greater depletion of intracellular GSH at day
9 and at day 30 compared to either DEP or OVA exposure alone.

OVA-Specific IgE and IgG Levels in Serum

In all samples collected on day 9, both serum IgE and IgG levels were under the
detection limits. On day 30, neither air- nor DEP-exposed rats exhibit measurable IgE
levels in the serum (Figure 8A). The OVA exposure, however, resulted in elevated IgE
level, and this antibody production was further enhanced in rats pre-exposed to DEP
(Figure 8A). The IgE level for the combined DEP and OVA exposure was 2.2-times
higher than that of the OVA exposure alone. Similarly, OVA sensitization also increased
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OVA-specific IgG production, and in combination with DEP exposure, resulted in an
even greater production of IgG (Figure 8B). The IgG level for the combined DEP and
OVA exposure was about 2-times higher than that of the OVA exposure alone. These
results indicate that DEP have an adjuvant effect on the production of both IgG and IgE.

Effects of DEP and OVA on Lung iNOS Expression

Immunohistochemical analysis of iNOS in lung tissues showed that AM from various
exposure groups did not stain for iNOS. At day 9 after DEP exposure, one of the five rats
in the combined DEP and OVA exposure showed slightly positive iNOS staining in the
airway epithelium. On day 30, two of the 5 rats from the combined exposure and one of
five rats from the OVA exposure alone showed positive airway staining. In comparison,
both AM and airway epithelia from LPS-treated animals were highly positive in iNOS
staining (data not shown).

4.2 Results for Protocol B

Lung Inflammation/Injury

The LDH activity and albumin content in the first fraction of acellular BAL fluid
(Figure 9) and the numbers of AM, eosinophils, neutrophils, and lymphocytes recovered
from BAL fluid (Figure 10) were determined as measurements of lung injury and airway
inflammation. None of DEP, OVA, or the combined OVA and DEP exposure induced
elevated levels of LDH activity and albumin content, indicating that the exposure
protocols did not cause significant lung injury that may complicate the experimental
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results. DEP exposure alone induced a moderate but significant increase in the number of
neutrophils recovered from BAL fluid. OVA exposure induced a greater infiltration of
neutrophils than DEP, and also resulted in infiltration of eosinophils and lymphocytes.
The OVA-induced eosinophil count was markedly increased by DEP, even though DEP
exposure alone had no effect on this cell type. In comparison, the OVA-mediated
infiltration of neutrophils and lymphocytes was not augmented by DEP in the combined
OVA-DEP exposure. These results show that DEP, under the current dose and exposure
protocol, did not cause substantial inflammation to the lung or augment OVA- induced
neutrophil and lymphocyte infiltration, but strongly enhanced the infiltration of
eosinophils that mediates airway inflammation and AHR.

Lymphocyte Population
The numbers of total lymphocytes, T cells, and their CD4+ and CD8+ subsets in
LDLN from rats sensitized and challenged by OVA were significantly higher than those
of the air-exposed, non-sensitized rats (Figure 11). While DEP exposure alone
moderately increased these lymphocyte counts, the combined DEP and OVA exposure
resulted in a substantial increase in the numbers of CD4+ and CD8+ T cells compared to
cell counts measured for OVA exposure alone.

ROS and NO Production

AM from various exposure groups were assessed for ROS production by
measurement of CL in response to zymosan stimulation (Figure 12). Exposure to DEP or
OVA alone had no effect on CL production by AM. However, a substantial elevation in
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CL was observed for the combined OVA and DEP exposure group. The production of
NO, a highly reactive nitrogen intermediate, was measured in the acellular BAL fluid
(Figure 13) and in AM-conditioned media (Figure 14). Both OVA and DEP exposures
resulted in increased presence of NO in the acellular BAL fluid and in AM-conditioned
media, and these levels were further increased in samples from the combined OVA and
DEP exposure.

The effect of DEP exposure on OVA-induced generation of nitrogen species and
reactive oxygen was also studied in ATII cells isolated from the rats. The intracellular
presence of NO (Figure 15) and superoxide (Figure 16) were determined by flow
cytometry after the cells were stained with DAF-DA and DHE, the relative specific
probes for intracellular generation of NO and superoxide, respectively. The ATII cells
from OVA-exposed rats exhibited higher percentage of cells that produce NO and
superoxide than those of the air-exposed, non-sensitized rats. While DEP exposure alone
increased the percentage of ATII cells that produce superoxide but not NO, the combined
DEP and OVA exposure resulted in significant increase in the percentage of the cells that
produce NO (Figure 15) and superoxide (Figure 16) over the control.

GSH Levels in AM and Lymphocytes

The levels of GSH in AM and lymphocytes from DEP or OVA-exposed rats were not
significantly changed compared to the controls (Figure 17). Under combined DEP and
OVA exposure, however, the intracellular GSH levels were significantly reduced in both
cell types compared to all other groups.
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OVA-specific IgE and IgG Production

In all the samples collected from non-sensitized rats, both IgE and IgG concentrations
were under the detection limits. OVA sensitization resulted in a significant production of
antigen-specific IgE, and its level was 2-times higher in rats that received the combined
OVA and DEP exposure than in rats sensitized to OVA but exposed to air (Figure 18A).
OVA sensitization also resulted in the production of OVA-specific IgG, whose level was
likewise increased, 1.7 fold, by DEP exposure (Figure 18B). DEP exposure alone had no
effect on IgG production. These results indicate that DEP exposure augments the
immune responses of rats to OVA in the production of allergen-specific IgE and IgG.

Airway Reactivity

The effect of DEP exposure on OVA-induced AHR was evaluated from Penh values
in rats from various treatment groups following MCh challenge (Figure 19). The baseline
Penh values were not significantly affected by OVA or DEP. However, airway
responsiveness to MCh was significantly increased in rats from the combined OVA and
DEP, whereas it was not in rats from other exposure groups. Thus, DEP exposure had a
synergistic effect with OVA on inducing AHR in rats.

iNOS Expression

Immunohistochemical analysis for iNOS expression in lung tissues showed no
staining of AM in any exposure group. However, the airway epithelium was found
positive in all five rats from the combined DEP and OVA exposure, 3 out of 5 rats from
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DEP or OVA exposure alone, and 2 out of 5 rats from the air-exposed, non-sensitized
control (data not shown). The OVA exposure was also found to increase iNOS expression
in AM and ATII cells isolated from the rats as detected by Western blot analysis (Figure
20). Although DEP exposure alone did not induce iNOS in AM and ATII cells, the
combined DEP and OVA exposure resulted in a significantly higher iNOS expression in
these cells than those from any other groups.

4.3 Results of Effects of DEP on B Lymphocytes and Cytokine Production

OVA-specific IgE Production

OVA-specific Ig E production by B lymphocytes isolated from saline, DEP, and LPS
exposed rats showed no difference on day7, day14 and day21 (figure 21).

Cytokine Production

IL-1β and IL-10 production in blood serum showed no difference between different
treatment groups (figure 22 + 23). However, LPS exposure resulted in a great increase in
the IL-6 production in blood samples compared with that from saline and DEP treated
rats (figure 24).
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Figure 1. Yield of (A) LDH activity and (B) albumin content in bronchoalveolar lavage
(BAL) fluid from rats (n = 5). *Significantly different from air + saline group, p < 0.05;
+
Significantly different from air + OVA group, p < 0.05.
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Figure 2. Total numbers and differentials of BAL cells recovered at (A) day 9 and (B)
day 30 post-DEP exposure (n = 5). *Significantly different from air + saline group, p <
0.05; +Significantly different from air + OVA group, p < 0.05. AM: alveolar
macrophages, PMN: polymorphonuclear neutrophils, LYM: lymphocytes, EOS:
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Figure 3. Concentrations of NO in BAL fluid. *Significantly different from air + saline
group, p < 0.05; +Significantly different from air + OVA group, p < 0.05.
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group, p < 0.05.
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Significantly different from air + OVA group, p < 0.05.
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from air + OVA group, p < 0.05.
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Figure 13. Nitrite in BAL fluid. Values are expressed as the means ± SE (n = 5).
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Significantly different from air + saline group, p < 0.05; +Significantly different from air
+ OVA group, p < 0.05.
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Figure 14. Nitrite in AM-conditioned media. Values are expressed as the means ± SE (n
= 5). *Significantly different from air + saline group, p < 0.05; +Significantly different
from air + OVA group, p < 0.05.
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Figure 15. Flow cytometric analysis of intracellular generation of NO by ATII cells.
Values are expressed as the means ± SE (n = 5). *Significantly different from air + saline
group, p < 0.05; +Significantly different from air + OVA group, p < 0.05.
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Figure 16. Flow cytometric analysis of intracellular generation of superoxide by ATII
cells. Values are expressed as the means ± SE (n = 5). *Significantly different from air +
saline group, p < 0.05; +Significantly different from air + OVA group, p < 0.05.
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Figure 22. Production of IL-1β in serum in different exposure groups. BN rats were
exposed to saline, DEP by i.t. and LPS by i.p.. Values are expressed as the means ± SE (n
= 4).
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Figure 23. Production of IL-10 in serum in different exposure groups. BN rats were
exposed to saline, DEP by i.t. and LPS by i.p.. Values are expressed as the means ± SE (n
= 4).
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Figure 24. Production of IL-6 in serum in different exposure groups. BN rats were
exposed to saline, DEP by i.t. and LPS by i.p.. Values are expressed as the means ± SE (n
= 4). *Significantly different from saline group, p < 0.05.
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5. DISCUSSION
Experimental models of asthma, as in BN rats, require a sensitization period for the
animal to develop the allergic response. Diesel exhaust particle exposure, on the other
hand, is known to induce acute inflammatory responses through particle stimulation but
anti-inflammatory responses through the organic component of DEP (Yin et al., 2004b;
Ma and Ma, 2002). Hence, the effects of DEP on allergic responses may vary depending
on the sensitization process and the timing of DEP exposure. In practical settings,
subjects may be sensitized or nonsensitized to an allergen and may encounter DEP and
allergen exposure at different time points, thus making the timing of DEP exposure an
important factor for assessment of allergic responses. The present study was designed to
characterize the effect of short-term DEP exposure on OVA-mediated airway responses
and mechanism of DEP exposure on altering OVA induced airway inflammation and
antigen-specific IgE and IgG production under two exposure protocols using an OVAallergic rat model. The dose for DEP exposure (22.7 ± 2.5 mg/m3) appears to be high in
comparison to the reported environmental and occupational concentrations, but in fact it
results in a lung deposition (402 ± 58 µg/rat) that is relevant to both non-occupational and
occupational exposure settings as discussed previously (Yin et al., 2002, 2004a). The
results showed that in both protocols, the inhaled DEP enhanced the sensitization of rats
to OVA in antigen-specific antibody production. This result, together with that from
previous studies, suggests that frequent exposure to DEP may alter allergy-related
responses in both previously sensitized and nonsensitized individuals, thus contributing
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to the manifestations and increased prevalence of asthma (Lovik et al., 1997; DiazSanchez et al., 1994, 1997; Takano et al., 1997).

DEP are carbon-based particles containing various organic compounds adsorbed onto
the carbonaceous core. The organic component-mediated reactive oxygen species (ROS)
generation plays an important role in cell-mediated immune responses (Yin et al., 2004b;
Ma and Ma, 2002; Whitekus et al., 2002). The imbalance between cellular antioxidants
and ROS levels can lead to oxidative stress and a depletion of intracellular thiol levels.
Increasing clinical, epidemiological, and experimental evidence indicates that excess
production of ROS and defective endogenous antioxidant defense mechanisms are
associated with asthma (Henricks and Nijkamp, 2001). Glutathione-S-transferases
(GSTs), for example, have been shown to be key regulators of the adjuvant effects of
DEP on allergic responses. Compared with patients with a functional genotype,
individuals with GSTM1 null or the GSTP1 I105 wild type genotypes showed enhanced
nasal allergic responses in the presence of DEP, including increased production of
antigen-specific IgE (Gilliland et al., 2004). As an important immune modulator,
intracellular GSH has a regulatory role in antigen presenting cells, including AM,
dendritic cells, and B cells, which is critical for the development of T cell-mediated
immunity and the predominance of cellular production of Th1 or Th2 cytokines (Peterson
et al., 1998; Ma and Ma, 2002; Murata et al., 2002). Our studies in protocol A showed
that DEP exposure alone markedly reduced the levels of GSH in lymphocytes and, to a
lesser extend, in AM at 9 and 30 days post DEP exposure, and that the combined DEP
and OVA exposure resulted in a synergistic depletion of GSH in both cell types.
However, the OVA-induced CD4+ T cells and AM secretion of IL-10 and IL-12 were
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significantly decreased by DEP, while two other cytokines (IL-4 and IFN-γ) were not
successfully detected. The fact that DEP aggravate intracellular GSH depletion in AM
and lymphocytes suggests that the organic component of DEP, which induces
intracellular ROS (Yin et al., 2004b), may play a role in the elevation of antigen-specific
IgE and IgG. Although a clear switch of T-cell immunity toward Th2 response in terms
of cytokine profile cannot be concluded from this study, elevated levels of OVA-specific
IgE and IgG in the DEP plus OVA group strongly suggest the occurrence of this switch
in vivo.

In protocol A we also showed that DEP exposure prior to OVA sensitization
inhibited allergen-induced airway inflammation measured at 4 weeks post exposure. In
agreement with this finding, we have previously shown that preexposure to DEP
significantly decreased the number of inflammatory cells (AM and neutrophiles) in the
lung and T cells and their CD4+ and CD8+ subsets in LDLN recovered from Listeria
monocytogenes- infected BN rats (Yin et al., 2004a). Inhibition of OVA-induced airway
inflammation by DEP as shown by the BAL cell differentials in this study, albeit not an
unexpected effect, contrasted with that reported previously (Takano et al., 1998;
Miyabara et al., 1998a; Sagai et al., 1996). This discrepancy suggests that DEP may have
multiple effects on allergic responses, depending on the status of the lung inflammation
induced by both allergens and particles. On one hand, DEP exhibit time-dependent
effects on allergen-induced airway inflammatory responses by increasing allergic
inflammation in already-sensitized individuals or during the sensitization process, but
attenuating these responses induced by delayed sensitization in previously nonsensitized
individuals. On the other hand, local inflammation induced by DEP (or other particles),
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which is significant or not, depending on the doses and timing for exposure, is another
important factor for DEP to affect allergen-related inflammation. In concurrent exposure
studies, the aggravation of allergen-induced inflammatory responses by DEP, such as
those reported by Takano et al. (1997, 1998), is expected, since the acute pulmonary
responses to DEP exposure alone also involve inflammatory cell infiltration, airway
inflammation, and altered lymphocyte function (Miyabara et al., 1998a; Sagai et al.,
1996; Takano et al., 1998). In protocol A, no significant acute inflammatory response or
lung injury was expected, while we did not examine the acute pulmonary response of rats
to DEP exposure. According to the same exposure dose and protocol, DEP alone did not
induce significant acute inflammatory responses and lung injury in BN rats as shown by
the previous results (Yin et al., 2004a).

The mechanism through which inhaled DEP inhibit the allergen-induced airway
inflammation in protocol A is complex but may involve a number of factors including
NO, ROS, and their effects on cellular cytokine production. Studies in rats and mice have
shown that NO production from lung cells (epithelial cells, macrophages, and Th1 cells)
may down-regulate Th1 cell-derived IFN-γ production and concomitantly up-regulate
local expression of Th2 cell-derived IL-4 and IL-5 (Barnes and Liew, 1995), thus
promoting the development of pulmonary eosinophilia and airway hyperreactivity (Liu et
al., 1997; Feder et al., 1997). Although immunohistochemical analysis of lung tissues
failed to detect alterations in iNOS expression in AM, the current study in protocol A
showed that inhaled DEP significantly inhibit OVA-induced NO production in AMconditioned media and BAL fluid, and this corresponds to an attenuation of OVA
induced eosinophilia. It has been known that DEP, through the organic compounds,
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induce cellular expression of antioxidative enzymes that contribute to the antiinflammatory responses. One such enzyme is heme oxygenase-1 (HO-1). We have shown
previously that DEP up-regulated expression of HO-1 in AM through a mechanism that
involves the organic component-induced CYP1A1 and ROS generation (Rengasamy et
al., 2003; Yin et al., 2004b). Studies have shown that HO-1 may act through carbon
monoxide, a major catalytic byproduct of HO-1-mediated heme degradation, which,
interestingly, has also been shown to reduce allergen induced airway
hyperresponsiveness and eosinophilia (Chapman et al., 2001). Additionally, studies in
animal models of allergic asthma showed that CD8-deficent mice or those with depleted
CD4+T cells developed significantly lowered airway hyperresponsiveness and
eosinophilic inflammation, indicating an important role of these T-cell subsets in airway
eosinophilia (Miyahara et al., 2004b; Gavett et al., 1994; Komai et al., 2003). The
inhibition of OVA-induced CD4+ and CD8+ T lymphocytes by DEP exposure, as
demonstrated in our study, thus may also contribute to its attenuation of allergic airway
inflammation.

AM play a pivotal role in controlling and directing immune responses by secreting a
variety of mediators including both pro-inflammatory and anti-inflammatory cytokines.
We and others have shown previously that in vivo or in vitro exposure to DEP suppressed
AM phagocytotic capacity and their secretion of pro-inflammatory cytokines, such as IL1β, IL-12, and TNF-α, in response to bacterial infection or LPS stimulation (Amakawa et
al., 2003; Saito et al., 2002; Yin et al., 2002). These studies indicated that DEP exposure
dampened AM function and responses to external stimuli and that DEP may play a role in
reducing inflammation. Indeed, DEP, at low dose were shown to exert an anti-
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inflammatory effect on bacteria-induced lung inflammation in rats (Yin et al., 2004a).
Consistent with these results, the current study in protocol A showed that DEP
significantly suppressed AM secretion of NO, IL-10, and IL-12 in response to OVA
stimulation. In view of the decreased lung inflammation in the combined DEP- and
OVA-exposed rats, the observed reduction in OVA-induced IL-10 by DEP seems
puzzling, since lines of evidence have led to the hypothesis that IL-10 may act as one of
the anti-inflammatory cytokines that regulate ongoing inflammatory responses (de Vries,
1995). In fact, the regulatory role of endogenous IL-10 in asthma remains unclear.
Previous studies have reported that IL-10 production in response to LPS was impaired in
the monocyte/macrophage cell lineage of asthmatics (Borish et al., 1996; John et al.,
1998), whereas other studies have reported an increase of IL-10-producing T cells and
macrophages in asthmatic airways and a further increase of those cells after an allergen
challenge (Colavita et al., 2000; Magnan et al., 1998; Robinson et al., 1996).
Furthermore, experimental asthma studies using IL-10 knockout mice have provided
controversial results in which increased or decreased airway inflammatory responses to
allergen challenge were found (Justice et al., 2001; Makela et al., 2000; Yang et al.,
2000). Interestingly, the IL-10 knockout mice showed increased or no changeable Th2
responses including allergen-specific IgE production (Justice et al., 2001; Yang et al.,
2000). These results, together with that obtained from the current study, show that the
role of IL-10 in regulating allergen-related airway inflammatory responses may be very
complex and need to be further studied. On the other hand, one would speculate on a
decreased IgE production in the DEP-plus-OVA exposure group because AM antigen
presenting function may be also dampened. Since AM are poor antigen-presenting cells
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compared to dendritic cells (Nicod et al., 2000), inhibition of AM function by DEP may
not significantly affect the antigen presenting in the lung and subsequent antibody
production. Inhibition of AM function by DEP may be, at least in part, responsible for the
decreased production of both Th1 and Th2 cytokines as examined in the DEP plus OVA
exposed rats.

In protocol B, exposure of non-sensitized rats to DEP resulted in only a moderate
increase in neutrophils in the lung, and there was a clear absence of eosinophilic
inflammation, antibody responses, or AHR. However, in OVA-sensitized rats, preexposure to DEP markedly enhanced OVA-induced AHR, eosinophils infiltration, and
serum OVA-specific IgE and IgG production. Although alterations in the lung cytokine
profile were unknown, the results show that DEP pre-exposure strongly enhances the
OVA-induced Th2 responses in antibody production as well as eosinophil-mediated
airway inflammation. To our knowledge, this is the first demonstration of a DEP
enhanced allergic AHR in rats. These results are consistent with, and complement those
obtained using various mouse models where DEP exposure was co-administered with
antigen challenge (Ichinose et al., 1997, 2002; Miyabara et al., 1998b; Takano et al.,
1997, 1998). It is interesting to point out that we demonstrated that DEP exposure prior to
the sensitization enhanced the sensitization in antibody production but inhibited airway
inflammation induced by OVA challenge using the same rat model (protocol A). Thus,
the action of DEP exposure on allergic asthma is such that it affects both the sensitization
and the asthmatic response of animals to the allergen.
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The mechanisms through which DEP alter the allergic reactions remain unclear in
part because of the complex, time-dependent effects of DEP on allergen-induced immune
responses. One of the cellular actions of DEP is the induction of intracellular ROS
through the organic component-mediated activation of cytochrome P450 1A1 and other
metabolic enzymes (Ma and Ma, 2002; Whitekus et al., 2002; Yin et al., 2004b). The
imbalance of cellular antioxidative responses to ROS generation induced by DEP leads to
oxidative stress and a reduction of total intracellular GSH in AM and lymphocytes (AlHumadi et al., 2002c). In protocol B we show that ROS generation in AM and ATII cells
is an important feature of the combined DEP and OVA exposure. As shown by CL
measurements, a marked increase in oxidant activity, which corresponds to a lowered
total GSH concentration in AM and lymphocytes, is associated with the combined DEP
and OVA exposure, which is greater than either DEP or OVA exposure alone. This
suggests that DEP preexposure augments ROS production by cells from OVA sensitized
rats. GSH, in addition to its role in protecting cells from oxidative injury, is critical to
macrophages and dendritic cells that act as antigen-presenting cells for the development
of T-cell–mediated immune responses. Depletion of GSH in these cells has been shown
to skew the development of T cells from Th1 to Th2 type (Murata et al., 2002; Peterson
et al., 1998), a manifestation of increased allergic asthmatic responses. That DEP
augment OVA-specific antibody production is consistent with the fact that DEP facilitate
depletion of GSH in AM and lymphocytes.

Nitric oxide has been considered an important marker in allergen-induced
inflammatory responses. This reactive nitrogen intermediate can directly react with and
deplete intracellular GSH (Folkes and Wardman, 2004) and may play a role in the
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development of eosinophilia and AHR in mouse and rat allergic models (Feder et al.,
1997; Liu et al., 1997). It has been shown that NO derived from iNOS in epithelial cells
promotes asthmatic inflammation by downregulating Th1 cells that secrete interferon-γ
and concomitantly upregulate Th2 cells that secrete IL-4 and IL-5 (Barnes and Liew,
1995). On the other hand, the constitutive NO-synthase (cNOS)–derived NO has been
shown to exert bronchoprotective effects in asthma including airway smooth muscle
relaxation and inhibition of smooth muscle proliferation (Ricciardolo et al., 2001, 2003).
In fact, NO derived from cNOS and from iNOS may play different roles in the airways.
The former seems to protect airways from excessive bronchoconstriction while the latter
has a modulatory role in inflammatory disorders of the airways such as asthma. The
effect of DEP pre-exposure, as shown in protocol B, is to increase iNOS expression in
AM and ATII cells of OVA sensitized and challenged rats, suggesting that DEP interact
directly with these lung cells. This interaction results in an acute response of increased
production of NO that is known to mediate OVA-induced eosinophilic inflammation and
AHR.

Our study shows an apparent linkage between the ROS and NO generation with
increased responses of T lymphocytes. Both DEP and OVA exposure in protocol B
enhanced the numbers of T cells and their CD4+ and CD8+ subsets recovered from the
LDLN in the BN rat model. But it was the combined DEP and OVA exposure that
yielded a substantial increase in T cell responses, which correlate with increased
production of ROS and NO and decreased level of GSH. Clinical investigations have
observed that CD4+ T lymphocytes and their secretion of Th2 cytokines played a central
role in initiating and sustaining asthmatic responses in the asthmatic airway (Robinson,

95

2000). Studies in animal models further showed that depletion of CD4+ T lymphocytes by
administration of anti-CD4 antibody inhibited allergen-induced airway eosinophilia and
AHR (Gavett et al., 1994; Komai et al., 2003). CD8+ T lymphocytes also play a role in
allergic responses. Miyahara et al. (2004a, b) showed that CD8-deficient mice had a
significantly lower AHR and eosinophilia in response to OVA sensitization and challenge
comparing to the wild-type, but the allergic response was fully restored by adoptive
transfer of antigen-primed effector CD8+ T cells.

Pulmonary type II cells are the principal cell type that expresses P450 and NOS
enzymes in the lung. The allergic asthma is associated with increased protein nitration
and airway inflammation due to the induction of iNOS in epithelial cells (Trifilieff et al,
2000; Iijima et al, 2001), suggesting that alteration of type II cell enzyme expression by
DEP may be responsible for the adjuvant effect of DEP on airway inflammation in
sensitized rats. To gain more insight, the effects of DEP and OVA on enzume expressions
and cellular production of reactive oxygen and nitrogen species were determined in
protocol B. Rats were sensitized with aerosolized OVA and exposed to DEP following
protocol B, sacrificed on Day 31, and analyzed for type II cell expression of CYP
enzymes and iNOS. Western blot analysis showed that OVA exposure alone induced
iNOS expression and slightly down-regulated CYP2B1. DEP exposure alone induced
CYP 1A1 but not iNOS expression. In combined exposure, however, DEP significantly
augmented the induction of iNOS by OVA. Flow cytometric analysis further showed that
DEP exposure alone increased the percentage of cells that produce superoxide but not
NO comparing to the control, OVA exposure alone moderately enhanced the percentage
of cells with increased NO and superoxide, but the combined exposure resulted in
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significant increase in the percentage of cells that produce NO, superoxide, and
peroxynitrite over either OVA or DEP exposure alone. These results show a positive
involvement of type II cells in the production of reactive oxygen and nitrogen species,
and suggest that this cell type is a target by DEP and OVA in the induction of airway
inflammation.
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